GLP-1 Market
LLY $1138.28 ▲ +2.0% NVO $43.45 ▲ +0.9% PFE $27.72 • 0.0% VKTX $31.53 ▼ -1.4% KLRA $13.75 ▼ -1.4% GPCR $38.44 ▼ -0.6% RHHBY $54.80 ▲ +3.9%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Omeprazole

Company
Nantes University Hospital
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
27 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

27 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 15, 2026

Find a Clinical Trial Near Me

See recruiting studies for Omeprazole and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02373280

    The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection

    Not yet reported Seoul National University Bundang Hospital 600 participants Est. completion 2027-12 1 site
    Other conditions: Helicobacter Infection
    View official trial listing →
  • Recruiting NCT NCT03365609

    A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children

    Not yet reported Ying HUANG 1440 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Helicobacter Infections
    View official trial listing →
  • Recruiting NCT NCT03866668

    A Study of Esomeprazole in Children With Autism

    Not yet reported Stanford University 25 participants Est. completion 2028-12 1 site
    Other conditions: Autism, Autism Spectrum Disorder
    View official trial listing →
  • Recruiting NCT NCT04448028

    Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial

    Not yet reported Universitätsklinikum Hamburg-Eppendorf 476 participants Est. completion 2028-02 1 site
    Other conditions: Liver Cirrhosis
    View official trial listing →
  • Recruiting NCT NCT05320796

    The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass

    Not yet reported Prof Urs Zingg 50 participants Est. completion 2027-12-31 1 site
    Other conditions: Obesity, Gastric Reflux, Ulcer, Gastric
    View official trial listing →
  • Recruiting NCT NCT05517928

    A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis

    Not yet reported Mayo Clinic 30 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Recruiting NCT NCT05582174

    PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers

    Not yet reported Chinese University of Hong Kong 594 participants Est. completion 2028-07-03 8 sites
    Other conditions: Upper GI Bleeding, Proton Pump Inhibitors
    View official trial listing →
  • Recruiting NCT NCT05799105

    OPEN Versus InTact Capsule Proton Pump Inhibitors for the Treatment of Marginal Ulcers

    Not yet reported Stephen Firkins 122 participants Est. completion 2027-03-23 1 site Stand-alone
    Other conditions: Marginal Ulcer
    View official trial listing →
  • Recruiting NCT NCT05874570

    Doxycycline for Helicobacter Pylori Rescue Treatment

    Not yet reported Shanghai Jiao Tong University School of Medicine 368 participants Est. completion 2025-10-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Recruiting NCT NCT06114836

    GERD Infant Feeding Therapeutics Trial (GIFT Trial)

    Not yet reported Nationwide Children's Hospital 369 participants Est. completion 2028-11-01 1 site
    Other conditions: GERD in Infants
    View official trial listing →
  • Recruiting NCT NCT06150898

    Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)

    Not yet reported Jules Bordet Institute 112 participants Est. completion 2027-10 1 site Stand-alone
    Other conditions: Early-stage Breast Cancer, Estrogen-receptor-positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06255886

    Treatment of Gastroesophageal Reflux Disease in Infants

    Not yet reported Odense University Hospital 96 participants Est. completion 2026-12-26 3 sites
    Other conditions: Gastroesophageal Reflux, Infant, Newborn, Diseases
    View official trial listing →
  • Recruiting NCT NCT06393868

    Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism

    Not yet reported Ottawa Hospital Research Institute 360 participants Est. completion 2028-03 7 sites Stand-alone
    Other conditions: Venous Thromboembolism, Gastro Intestinal Bleeding, Blood Clot
    View official trial listing →
  • Recruiting NCT NCT06546111

    Clinical Study to Evaluate the Possible Efficacy and Safety of Diosmin and Hesperidin Combined Therapy in Patients With Helicobacter Pylori Infection

    Not yet reported, Not yet reported Sadat City University 46 participants Est. completion 2026-10-01 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Recruiting NCT NCT06562907

    Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)

    Not yet reported Gilead Sciences 134 participants Est. completion 2026-11 3 sites Stand-alone
    Other conditions: Weight Management
    View official trial listing →
  • Recruiting NCT NCT06690164

    Study on the Effect of Atorvastatin Co-administered With Omeprazole on Statin Lactone

    Not yet reported National University Hospital, Singapore 78 participants Est. completion 2026-06 1 site Stand-alone
    Other conditions: Metabolite
    View official trial listing →
  • Recruiting NCT NCT06693960

    Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach

    Not yet reported Washington State University 16 participants Est. completion 2027-01-31 1 site Stand-alone
    Other conditions: Interaction
    View official trial listing →
  • Recruiting NCT NCT06733675

    Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

    Not yet reported Basilea Pharmaceutica 96 participants Est. completion 2026-12-30 1 site
    Other conditions: Healthy Volunteer, Pharmacokinetics, Safety, Drug-Drug Interaction (DDI), FDC
    View official trial listing →
  • Recruiting NCT NCT06850480

    A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis

    Not yet reported Livzon Pharmaceutical Group Inc. 356 participants Est. completion 2025-04-30 1 site
    Other conditions: Reflux Esophagitis (RE)
    View official trial listing →
  • Recruiting NCT NCT06861478

    PPIs and In-Hospital Morbidity in Acute Variceal Bleeding With Chronic Liver Disease

    Not yet reported Universidad Autonoma de Nuevo Leon 60 participants Est. completion 2026-09-20 1 site Stand-alone
    Other conditions: Morbidity
    View official trial listing →
  • Recruiting NCT NCT06955520

    Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM

    Not yet reported Asian Institute of Gastroenterology, India 300 participants Est. completion 2028-12-25 1 site
    Other conditions: GERD
    View official trial listing →
  • Recruiting NCT NCT06999577

    The Mechanism Versus PPI Trial

    Not yet reported University of California, San Diego 160 participants Est. completion 2029-07-01 1 site
    Other conditions: Laryngopharyngeal Reflux, Cough, Throat Clearing, Dysphonia, Reflux
    View official trial listing →
  • Recruiting NCT NCT07139366

    Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment

    Not yet reported Yongquan Shi 1248 participants Est. completion 2026-09 1 site
    Other conditions: Gastritis, Dyspepsia, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer
    View official trial listing →
  • Recruiting NCT NCT07268820

    Heartburn, Gastroesophageal Reflux Disease

    Not yet reported Incheon St.Mary's Hospital 160 participants Est. completion 2026-09-30 10 sites
    Other conditions: GERD
    View official trial listing →
  • Recruiting NCT NCT07293910

    Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

    Not yet reported Tanta University 132 participants Est. completion 2026-12-20 1 site
    Other conditions: HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection, Helicobacter Pylori Gastrointestinal Tract Infection, Helicobacter Pylori Infected Patients
    View official trial listing →
  • Recruiting NCT NCT07665723

    An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis

    Not yet reported Hoffmann-La Roche 25 participants Est. completion 2030-12-31 17 sites Stand-alone
    Other conditions: Active Ulcerative Colitis
    View official trial listing →
  • Recruiting NCT NCT07797959

    Thread-Embedding Acupuncture as an Adjunct to Proton Pump Inhibitor Therapy for Gastroesophageal Reflux Disease

    Not yet reported University of Science Ho Chi Minh City 50 participants Est. completion 2026-09-18 1 site Stand-alone
    Other conditions: GERD, Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00001191

    The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Est. completion 2007-12-10 1 site
    Other conditions: Gastrinoma, Zollinger Ellison Syndrome
    View official trial listing →
  • Completed NCT NCT00001337

    Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

    Not yet reported National Cancer Institute (NCI) 348 participants Est. completion 2024-05-24 5 sites Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma, Burkitt Lymphoma, Anaplastic Large-Cell Lymphoma, Gray Zone Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00003617

    Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach

    Not yet reported Lymphoma Trials Office 200 participants 30 sites
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00069823

    Study of Acid Reflux in Asthma

    Not yet reported Johns Hopkins Bloomberg School of Public Health 403 participants Est. completion 2008-05 20 sites
    Other conditions: Asthma, Lung Diseases, Lung Diseases, Obstructive
    View official trial listing →
  • Completed NCT NCT00120315

    Proton Pump Inhibitor Treatment Stop

    Not yet reported Odense University Hospital 171 participants Est. completion 2007-03 1 site
    Other conditions: Dyspepsia
    View official trial listing →
  • Completed NCT NCT00123656

    Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis

    Not yet reported University of Utah 30 participants Est. completion 2006-12 1 site
    Other conditions: Esophagitis
    View official trial listing →
  • Completed NCT NCT00141102

    Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 4484 participants Est. completion 2009-05 194 sites
    Osteoarthritis Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT00149851

    A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)

    Not yet reported Novartis 832 participants Est. completion 2005-06 1 site
    Other conditions: Symptomatic Gastroespohageal Reflux Disease
    View official trial listing →
  • Status unknown NCT NCT00162877

    The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships

    Not yet reported National Taiwan University Hospital 80 participants Est. completion 2005-04 1 site
    Other conditions: Peptic Ulcer With H. Pylori Infection, Gastritis With H. Pylori Infection
    View official trial listing →
  • Terminated NCT NCT00164788

    A Comparison of Gastric pH Control With High Dose Intravenous or Oral Esomeprazole

    Not yet reported Chinese University of Hong Kong 7 participants Est. completion 2011-01 1 site
    Other conditions: Gastrointestinal Hemorrhage
    View official trial listing →
  • Completed NCT NCT00164866

    Administration of High-Dose Intravenous Proton Pump Inhibitor for Upper Gastrointestinal Bleeding Prior to Endoscopy

    Not yet reported Chinese University of Hong Kong 638 participants Est. completion 2005-09 1 site
    Other conditions: Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT00164931

    A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer

    Not yet reported Chinese University of Hong Kong 240 participants 1 site
    Other conditions: Peptic Ulcer Hemorrhage
    View official trial listing →
  • Completed NCT NCT00182260

    A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Treatment of Patients With Chronic GERD

    Not yet reported McMaster University 216 participants Est. completion 2010-04 1 site
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00184522

    On Demand Treatment of Reflux Disease

    Not yet reported Norwegian University of Science and Technology 82 participants Est. completion 2004-12 9 sites
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00206050

    Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po

    Not yet reported AstraZeneca 40 participants Est. completion 2004-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00206180

    NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis

    Not yet reported AstraZeneca 120 participants Est. completion 2005-08 39 sites
    Other conditions: Erosive Esophagitis, Reflux Esophagitis, Gastroesophageal Reflux Disease
    View official trial listing →
  • Terminated NCT NCT00206440

    Nexium Study To Suppress Nausea During Chemotherapy

    Not yet reported Baylor Breast Care Center 43 participants Est. completion 2012-02 1 site
    Other conditions: Nausea
    View official trial listing →
  • Completed NCT NCT00210470

    A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer

    Not yet reported Brooklyn ImmunoTherapeutics, LLC 27 participants Est. completion 2012-03 Stand-alone
    Other conditions: Squamous Cell Carcinoma of the Head and Neck
    View official trial listing →
  • Completed NCT NCT00225238

    The Effects of Nexium on the Side Effects Associated With a Colonoscopy Prep

    Not yet reported Thomas Jefferson University 500 participants Est. completion 2007-10 1 site
    Other conditions: Nausea, Vomiting, Abdominal Pain
    View official trial listing →
  • Completed NCT NCT00226044

    Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.

    Not yet reported Rijnstate Hospital 17 participants Est. completion 2017-09 1 site
    Other conditions: Gastroesophageal Reflux, Esophageal Atresia, Hernia, Diaphragmatic
    View official trial listing →
  • Completed NCT NCT00230516

    Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects

    Not yet reported AstraZeneca 100 participants Est. completion 2006-02 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00241501

    Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients

    Not yet reported AstraZeneca 140 participants Est. completion 2005-04 40 sites
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00241553

    Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

    Not yet reported AstraZeneca 276 participants Est. completion 2003-02 136 sites
    Other conditions: NSAIDs, Upper GI Symptoms
    View official trial listing →
  • Completed NCT NCT00243724

    HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease

    Not yet reported AstraZeneca 350 participants Est. completion 2007-06 10 sites
    Other conditions: Gastroesophageal Reflux, Heartburn, Dyspepsia
    View official trial listing →
  • Withdrawn NCT NCT00247130

    Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer

    Not yet reported Keio University Est. completion 2007-07 1 site
    Other conditions: Peptic Ulcers
    View official trial listing →
  • Completed NCT NCT00251030

    A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects

    Not yet reported Pfizer 20 participants Est. completion 2006-01 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00251914

    Nexium Dyspepsia/AST

    Not yet reported AstraZeneca 1500 participants Est. completion 2005-01 215 sites
    Other conditions: Gastrointestinal Disease, Signs and Symptoms, Digestive, Dyspepsia
    View official trial listing →
  • Completed NCT NCT00256737

    Sopran - Omeprazole Treatment Versus Surgery

    Not yet reported AstraZeneca 219 participants Est. completion 2005-10 13 sites
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00290823

    Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 110 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Neurocysticercosis
    View official trial listing →
  • Completed NCT NCT00303264

    The Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia.

    Not yet reported Forest Laboratories 48 participants Est. completion 2007-08 1 site
    Other conditions: Dyspepsia
    View official trial listing →
  • Completed NCT NCT00327132

    Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment Outcome

    Not yet reported National Health Research Institutes, Taiwan 47 participants Est. completion 2015-12 6 sites Stand-alone
    Other conditions: Gastric MALT Lymphoma
    View official trial listing →
  • Completed NCT NCT00339768

    A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province

    Not yet reported National Cancer Institute (NCI) 3411 participants Est. completion 1996-06-10 1 site Stand-alone
    Other conditions: Precancerous Gastric Lesions
    View official trial listing →
  • Completed NCT NCT00349661

    Influence Of Omeprazole On The Anti-Platelet Action Of Clopidogrel

    Not yet reported University Hospital, Brest 120 participants Est. completion 2006-12 1 site
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00350155

    Video Capsule Endoscopy to Investigate the Safety and Tolerability of Lumiracoxib in the Small Bowel

    Not yet reported Novartis 150 participants 2 sites
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Withdrawn NCT NCT00361985

    Study of Proton Pump Inhibitors (PPI) to Prevent Strictures After Gastric Bypass Surgery

    Not yet reported Weill Medical College of Cornell University Est. completion 2011-07 1 site
    Other conditions: Anastomotic Stricture, Morbid Obesity
    View official trial listing →
  • Status unknown NCT NCT00363701

    Study of Long-Term Use of Proton-Pump-Inhibitors in General Practice

    Not yet reported Glostrup University Hospital, Copenhagen 150 participants Est. completion 2008-02 1 site
    Other conditions: Dyspepsia, Gastroesophageal Refluxdisease, Ulcer
    View official trial listing →
  • Withdrawn NCT NCT00364481

    Tongue Exercises and Reflux Therapy for Upper Airway Resistance Syndrome

    Not yet reported West Side ENT Est. completion 2007-08
    Obstructive sleep apnea Other conditions: Upper Airway Resistance Syndrome, Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00374101

    High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding

    Not yet reported Casa Sollievo della Sofferenza IRCCS 450 participants Est. completion 2007-03 10 sites
    Other conditions: Peptic Ulcers, Upper Gastrointestinal Bleeding
    View official trial listing →
  • Completed NCT NCT00384592

    PPI Sequencing Study

    Not yet reported AstraZeneca 100 participants Est. completion 2007-05 14 sites
    Other conditions: Gastro-Oesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00392002

    Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response

    Not yet reported AstraZeneca 2000 participants Est. completion 2007-05 2 sites
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00401752

    Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric Ulcer

    Not yet reported AstraZeneca 397 participants Est. completion 2008-11 9 sites
    Other conditions: Gastric Ulcer
    View official trial listing →
  • Completed NCT NCT00402259

    Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding

    Not yet reported AstraZeneca 440 participants Est. completion 2007-10 7 sites
    Other conditions: Gastrointestinal Hemorrhage
    View official trial listing →
  • Completed NCT NCT00410592

    Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD

    Not yet reported AstraZeneca 90 participants Est. completion 2007-05 8 sites
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00426452

    A Drug-drug Interaction Study of Oral 1250 mg of Vatalinib Administered Under Fasting and Fed Conditions With a Proton-pump Inhibitor in Healthy Sterile or Postmenopausal Female Volunteers

    Not yet reported Novartis 24 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00427635

    Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal Patients

    Not yet reported AstraZeneca 32 participants Est. completion 2009-04 3 sites
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00441519

    A Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin

    Not yet reported POZEN 80 participants Est. completion 2007-04 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00442208

    An Open-Label, Randomized, Comparative 3-Way Cross-Over Study to Evaluate the Effect of Food on the 24-Hour Intragastric pH at Day 5 After Twice Daily Oral Administration of PN 200 (Omeprazole/Naproxen) in Healthy Volunteers

    Not yet reported POZEN 24 participants Est. completion 2008-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT00442741

    Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension)

    Not yet reported Novartis Pharmaceuticals Stand-alone
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT00446004

    Effect of a Proton Pump Inhibitor on Gleevec® in Healthy Volunteers

    Not yet reported University of Pittsburgh 15 participants Est. completion 2009-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT00455754

    Esomeprazole Treatment for Patients With Lymphocytic Gastritis

    Not yet reported Technische Universität Dresden 40 participants Est. completion 2009-12 1 site
    Other conditions: Lymphocytic Gastritis
    View official trial listing →
  • Status unknown NCT NCT00455806

    Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection

    Not yet reported Technische Universität Dresden 132 participants Est. completion 2008-02 9 sites
    Other conditions: Helicobacter Pylori Infection, Chronic Gastritis
    View official trial listing →
  • Completed NCT NCT00464308

    A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg

    Not yet reported Janssen-Cilag Pty Ltd 1392 participants Est. completion 2008-05 25 sites
    Other conditions: Gastro-oesophageal Reflux
    View official trial listing →
  • Status unknown NCT NCT00471029

    Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer

    Not yet reported Pamela Youde Nethersole Eastern Hospital 20 participants Est. completion 2007-09 1 site
    Other conditions: Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT00472550

    Esomeprazole and Gastric Emptying of Beer

    Not yet reported Heidelberg University 16 participants Est. completion 2006-11 1 site
    Other conditions: Gastroesophageal Reflux, Heartburn
    View official trial listing →
  • Completed NCT NCT00474903

    Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus

    Not yet reported National Cancer Institute (NCI) 122 participants Est. completion 2011-06 1 site
    Other conditions: Barrett Esophagus, Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT00492622

    Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis

    Not yet reported University of Louisville 12 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Gastroparesis, Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00501774

    A Search for Helicobacter Pylori in Localized Vulvodynia

    Western Galilee Hospital-Nahariya 27 participants Est. completion 2007-06 1 site
    Other conditions: Vulvodynia, Vulvar Vestibulitis
    View official trial listing →
  • Status unknown NCT NCT00516971

    The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese Population

    Not yet reported Hospital Authority, Hong Kong 200 participants Est. completion 2008-12 1 site
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00524251

    The Effect of Lifestyle-Adjustments Prior to Medical Treatment on the Effect of Medical Treatment in Reflux Patients

    AstraZeneca 990 participants Est. completion 2008-03 54 sites
    Other conditions: GERD, Quality of Life
    View official trial listing →
  • Completed NCT NCT00527904

    A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)

    Not yet reported POZEN 239 participants Est. completion 2009-03 1 site
    Other conditions: Gastric Ulcer
    View official trial listing →
  • Terminated NCT NCT00542347

    Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole

    Not yet reported Queen's University 20 participants Est. completion 2018-07 1 site
    Other conditions: Gastric Acid
    View official trial listing →
  • Completed NCT NCT00542789

    Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID

    Not yet reported AstraZeneca 343 participants Est. completion 2009-02 39 sites
    Osteoarthritis Other conditions: Gastric Ulcer, Duodenal Ulcer, Rheumatoid Arthritis, Lumbago
    View official trial listing →
  • Completed NCT NCT00557349

    Ulcer Prevention Study in Post Gastric Bypass Patients

    Not yet reported University of Missouri-Columbia 40 participants Est. completion 2008-03 1 site
    Other conditions: Marginal Ulcers
    View official trial listing →
  • Terminated NCT NCT00557921

    Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

    Not yet reported Cogentus Pharmaceuticals 5000 participants Est. completion 2009-11 491 sites Stand-alone
    Cardiovascular disease Other conditions: Acute Coronary Syndrome, Percutaneous Coronary Intervention
    View official trial listing →
  • Completed NCT NCT00559182

    A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001)

    Not yet reported Merck Sharp & Dohme LLC 47 participants Est. completion 2010-07-09 Stand-alone
    Other conditions: Advanced Cancer
    View official trial listing →
  • Completed NCT NCT00559364

    Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea

    Not yet reported Forest Laboratories 50 participants Est. completion 2009-07 18 sites Stand-alone
    Other conditions: Exocrine Pancreatic Insufficiency, Chronic Pancreatitis, Pancreatectomy
    View official trial listing →
  • Completed NCT NCT00574925

    Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients

    Not yet reported University of Zurich Est. completion 2007-10 1 site
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00582972

    Does Omeprazole Decrease Intestinal Calcium Absorption?

    Not yet reported University of Wisconsin, Madison 23 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Osteoporosis, Achlorhydria, GERD, Hip Fracture
    View official trial listing →
  • Completed NCT NCT00584922

    Early Detection and Treatment of Esophageal Injury After Catheter Ablation for Atrial Fibrillation

    University of Oklahoma 175 participants Est. completion 2011-12 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00590928

    Gastric pH in Critically Ill Patients

    Not yet reported Medical University of Vienna 75 participants Est. completion 2006-06 1 site
    Other conditions: Critically Ill Patients, Indication for Stress Ulcer Prophylaxis
    View official trial listing →
  • Completed NCT NCT00595517

    Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer

    Not yet reported AstraZeneca 395 participants Est. completion 2009-09 3 sites
    Osteoarthritis Other conditions: Gastric Ulcer, Duodenal Ulcer, Rheumatoid Arthritis, Lumbago
    View official trial listing →
  • Completed NCT NCT00625495

    Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)

    Not yet reported AstraZeneca 60 participants Est. completion 2002-11
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00626535

    A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)

    Not yet reported AstraZeneca 500 participants Est. completion 2004-02
    Other conditions: Symptomatic Gastroesophageal Reflux Disease (sGERD)
    View official trial listing →
  • Completed NCT NCT00628667

    Chronic Posterior Laryngitis With Suspected Laryngopharyngeal Reflux

    Not yet reported AstraZeneca 120 participants Est. completion 2003-03
    Other conditions: Chronic Posterior Laryngitis (CPL)
    View official trial listing →
  • Completed NCT NCT00628953

    Adult Asthmatics and Acid Reflux

    Not yet reported AstraZeneca 1400 participants Est. completion 2004-04
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00629512

    Prevention of Gastric Ulcers

    Not yet reported AstraZeneca 504 participants Est. completion 2002-12
    Other conditions: NSAID Associated Gastric Ulcers
    View official trial listing →
  • Completed NCT NCT00633412

    A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only

    Not yet reported AstraZeneca 400 participants Est. completion 2003-03
    Other conditions: NSAID Associated Gastric Ulcers
    View official trial listing →
  • Completed NCT NCT00633672

    A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued

    Not yet reported AstraZeneca 400 participants Est. completion 2003-10
    Other conditions: NSAID Associated Gastric Ulcers
    View official trial listing →
  • Completed NCT NCT00635414

    Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously

    Not yet reported AstraZeneca 60 participants Est. completion 2002-10
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00637845

    Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)

    Not yet reported AstraZeneca 248 participants Est. completion 2003-02
    Other conditions: Heartburn, Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00640809

    Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 408 participants Est. completion 2004-04 12 sites
    Other conditions: Bowel Diseases, Inflammatory
    View official trial listing →
  • Completed NCT NCT00641264

    Quality of Life Validation in Laryngitis

    Not yet reported AstraZeneca 90 participants Est. completion 2003-06
    Other conditions: Laryngopharyngeal Reflux (LPR)
    View official trial listing →
  • Completed NCT NCT00644735

    Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed

    Not yet reported AstraZeneca 750 participants Est. completion 2004-01
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Completed NCT NCT00644839

    Study Examing The Effect Of Omeprazole On Safety, Tolerability And How The Body Processes An Experimental Drug

    Not yet reported Pfizer 28 participants Est. completion 2008-07 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00658528

    Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

    Not yet reported Eisai Inc. 1061 participants Est. completion 2010-01 88 sites
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00658632

    Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)

    Not yet reported Eisai Inc. 1397 participants Est. completion 2009-09 85 sites
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00658775

    Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

    Not yet reported Eisai Inc. 1069 participants Est. completion 2010-01 83 sites
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00660660

    Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US

    Not yet reported AstraZeneca 276 participants Est. completion 2008-07 45 sites
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Terminated NCT NCT00668317

    Bronchial Hyper-responsiveness in Reflux Cough

    Not yet reported Hull University Teaching Hospitals NHS Trust 5 participants Est. completion 2010-01 1 site
    Other conditions: Cough
    View official trial listing →
  • Completed NCT NCT00684190

    Drug Interaction Study Between AZD3355 and Nexium

    Not yet reported AstraZeneca 30 participants Est. completion 2008-06 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00688428

    Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination

    Not yet reported AstraZeneca 84 participants Est. completion 2008-04
    Other conditions: Ulcers, Upper GI Symptoms
    View official trial listing →
  • Completed NCT NCT00693225

    Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study

    Not yet reported Yvonne Romero 91 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Completed NCT NCT00699426

    The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes

    Not yet reported Lise Tarnow 41 participants Est. completion 2009-06
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00719160

    The Effect of Protein on Calcium Absorption and Gastric Acid Production

    Not yet reported Yale University 12 participants Est. completion 2008-05 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00728481

    The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis

    Not yet reported, Not yet reported Mayo Clinic 51 participants Est. completion 2010-12 1 site
    Other conditions: Eosinophilic Esophagitis, Gastroesophageal Reflux Disease, EE, GERD
    View official trial listing →
  • Terminated NCT NCT00730665

    Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)

    Not yet reported Pfizer 81 participants Est. completion 2008-10 38 sites
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00734097

    A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)

    Not yet reported AstraZeneca 314 participants Est. completion 2008-10 10 sites
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00741468

    Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects

    Not yet reported Repros Therapeutics Inc. 18 participants Est. completion 2008-10 1 site Stand-alone
    Other conditions: Drug Interactions
    View official trial listing →
  • Completed NCT NCT00745849

    Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial

    Not yet reported University of Texas Southwestern Medical Center 43 participants Est. completion 2008-03 1 site
    Other conditions: Vasomotor Rhinitis
    View official trial listing →
  • Completed NCT NCT00772837

    Effect of Eradication of Helicobacter Pylori on the Dyspeptic Symptoms

    Not yet reported Aga Khan University 370 participants Est. completion 2009-01 1 site Stand-alone
    Other conditions: Functional Dyspepsia, Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT00786695

    Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCP

    Not yet reported National University Hospital, Singapore 60 participants Est. completion 2009-12 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00808769

    Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression

    Not yet reported Procter and Gamble 30 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Normal Healthy Subject Population
    View official trial listing →
  • Completed NCT NCT00817245

    Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR)

    Not yet reported, Not yet reported Tabriz University 50 participants Est. completion 2009-01 1 site
    Other conditions: Central Serous Chorioretinopathy
    View official trial listing →
  • Completed NCT NCT00854451

    Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection

    Not yet reported National Taiwan University Hospital 128 participants Est. completion 1998-02 1 site
    Other conditions: Duodenal Ulcer, Helicobacter Pylori Infection
    View official trial listing →
  • Withdrawn NCT NCT00881413

    Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding

    Not yet reported Lotung Poh-Ai Hospital
    Other conditions: Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT00903448

    Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression

    Not yet reported Procter and Gamble 40 participants Est. completion 2009-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT00915616

    The Potential Therapeutic Effect of Melatonin in Gastro-Esophageal Reflux Disease

    Not yet reported Mansoura University
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00930306

    AZD2066 Cocktail Study

    Not yet reported AstraZeneca 15 participants Est. completion 2009-09 2 sites Stand-alone
    Other conditions: Chronic Pain
    View official trial listing →
  • Completed NCT NCT00931073

    A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers

    Not yet reported Pfizer 24 participants Est. completion 2009-10 1 site Stand-alone
    Other conditions: Alzheimer's Disease, Huntington's Disease
    View official trial listing →
  • Completed NCT NCT00942136

    GSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose Study

    Not yet reported GlaxoSmithKline 24 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT00950339

    Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, or Famotidine

    Not yet reported Tel-Aviv Sourasky Medical Center 63 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Coronary Heart Disease, GI Bleeding
    View official trial listing →
  • Completed NCT NCT00953381

    Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)

    Not yet reported Livzon Pharmaceutical Group Inc. 235 participants Est. completion 2005-05 1 site
    Other conditions: Duodenal Ulcer
    View official trial listing →
  • Completed NCT NCT00960869

    Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

    Not yet reported POZEN 519 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Gastric Ulcer
    View official trial listing →
  • Completed NCT NCT00961350

    A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

    Not yet reported POZEN 530 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Gastric Ulcer
    View official trial listing →
  • Completed NCT NCT00964106

    Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation

    Not yet reported GlaxoSmithKline 87 participants Est. completion 2011-08-29 2 sites Stand-alone
    Other conditions: Drug Interactions
    View official trial listing →
  • Completed NCT NCT00971581

    Safety, Tolerability and Efficacy Study With a Fixed-Dose Combination (FDC) Ketoprofen Plus Omeprazole

    Not yet reported Sanofi 52 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Pain
    View official trial listing →
  • Status unknown NCT NCT00978159

    Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer Dyspepsia

    Not yet reported Ruttonjee Hospital 128 participants Est. completion 2013-12 2 sites
    Other conditions: Aspirin, Dyspepsia
    View official trial listing →
  • Terminated NCT NCT00981929

    Development of Cocktail for Measuring the Activity of Important Cytochrome P450 Enzymes

    Not yet reported University of Southern Denmark 412 participants Est. completion 2011-01 1 site
    Other conditions: Cytochrome P450 Phenotype and Genotype Metrics
    View official trial listing →
  • Completed NCT NCT00995410

    Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers

    Not yet reported POZEN 380 participants Est. completion 2011-05 1 site Stand-alone
    Other conditions: Aspirin-Associated Gastric Ulcers
    View official trial listing →
  • Completed NCT NCT00998075

    Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately

    Not yet reported AstraZeneca 138 participants Est. completion 2009-12 1 site
    Other conditions: Peptic Ulcer Disease
    View official trial listing →
  • Status unknown NCT NCT01000220

    Evaluation of Omeprazole Effect on Glaucoma

    Not yet reported Shahid Beheshti University of Medical Sciences 1 site
    Other conditions: Glaucoma
    View official trial listing →
  • Completed NCT NCT01005719

    Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED)

    Not yet reported Bayer 63 participants Est. completion 2010-01 Stand-alone
    Other conditions: Human Experimentation
    View official trial listing →
  • Completed NCT NCT01007019

    Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH4808 After Oral Administration in Healthy Male Subjects

    Not yet reported Yuhan Corporation 134 participants Est. completion 2012-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01061034

    Pharmacological Study That Measures Omeprazole Effect on Aspirins Absorption in Healthy Volunteers

    Not yet reported Assaf-Harofeh Medical Center 9 participants Est. completion 2007-06 1 site
    Other conditions: Aspirin Blood Level, Proton Pump Inhiditor Treatment
    View official trial listing →
  • Completed NCT NCT01069081

    Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer

    Not yet reported Fudan University 94 participants Est. completion 2012-02 1 site
    Other conditions: Breast Cancer, Metastasis, Neoplasm
    View official trial listing →
  • Completed NCT NCT01086722

    Pharmacokinetics in Morbid Obesity After Bariatric Surgery

    Not yet reported, Not yet reported Fundacion IMIM 52 participants Est. completion 2013-03 2 sites
    Other conditions: Morbid Obesity, Overweight
    View official trial listing →
  • Status unknown NCT NCT01089959

    Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD

    Not yet reported, Not yet reported Southern Arizona VA Health Care System 20 participants Est. completion 2012-03 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Status unknown NCT NCT01107938

    Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients

    Not yet reported Livzon Pharmaceutical Group Inc. 330 participants
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Terminated NCT NCT01109381

    Safety and Efficacy Study of a Non-antibiotic Treatment for the Eradication of Helicobacter Pylori

    Not yet reported, Not yet reported Synergy Pharmaceuticals Pte. Ltd. 33 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01119768

    Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients

    Not yet reported AstraZeneca 305 participants Est. completion 2011-06 8 sites
    Other conditions: Non Erosive Reflux Disease, Chronic Gastritis
    View official trial listing →
  • Completed NCT NCT01122160

    Gastric pH and Anthocyanin Absorption

    Not yet reported USDA Beltsville Human Nutrition Research Center 13 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Anthocyanin Metabolism
    View official trial listing →
  • Withdrawn NCT NCT01123031

    Oral vs Intravenous and Proton Pump Inhibitor (PPI）for Peptic Ulcer Bleeding (PUB)

    Not yet reported Changhua Christian Hospital Est. completion 2012-03
    Other conditions: Upper Gastrointestinal Bleeding
    View official trial listing →
  • Completed NCT NCT01129375

    Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects

    Not yet reported Sanofi 72 participants Est. completion 2009-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01129713

    Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.

    Not yet reported, Not yet reported Effexus Pharmaceutical 40 participants Est. completion 2015-05 1 site
    Other conditions: Gastroesophageal Reflux Disease (GERD), Heartburn, Indigestion
    View official trial listing →
  • Completed NCT NCT01136317

    Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects

    Not yet reported Nantes University Hospital Est. completion 2010-07 1 site Stand-alone
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT01138969

    Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer

    Not yet reported Kaohsiung Veterans General Hospital. 165 participants Est. completion 2012-12 1 site
    Other conditions: Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT01139645

    The Effect of Proton Pump Inhibitors on Calcium and Bone Metabolism

    Not yet reported American University of Beirut Medical Center 58 participants Est. completion 2010-07 1 site
    Other conditions: Calcium Metabolism Disorders
    View official trial listing →
  • Terminated NCT NCT01142128

    Viokase 16, Viokase16 Plus Nexium and Nexium Alone

    Not yet reported University of Florida 12 participants Est. completion 2012-03 1 site
    Other conditions: Chronic Pancreatitis
    View official trial listing →
  • Completed NCT NCT01142245

    Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy

    Not yet reported Chinese University of Hong Kong 263 participants Est. completion 2014-07 2 sites
    Other conditions: Peptic Ulcer, Bleeding
    View official trial listing →
  • Completed NCT NCT01147887

    A Pharmacokinetic and Drug Interaction Study of JNJ-26489112 in Healthy Volunteers

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 20 participants Est. completion 2010-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01150162

    Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation

    Not yet reported Otsuka Pakistan Limited 129 participants Est. completion 2012-08 3 sites Stand-alone
    Other conditions: Gastric Ulcer
    View official trial listing →
  • Completed NCT NCT01153659

    A Study to Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Esomeprazole (Nexium) 40 mg Capsules and Rabeprazole (Aciphex) 20-mg Tablets

    Not yet reported Eisai Inc. 90 participants Est. completion 2010-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01170169

    Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fasting Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 44 participants Est. completion 2006-03 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01170182

    Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fed Condition

    Not yet reported Dr. Reddy's Laboratories Limited 54 participants Est. completion 2006-04 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01188525

    Pharmacokinetic Study to Characterize Individual Metabolic Profile

    Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 10 participants Est. completion 2011-07 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01199328

    Study to Evaluate the Interaction Between Aspirin and Nexium

    Not yet reported AstraZeneca 34 participants Est. completion 2010-11 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01205087

    Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome

    Not yet reported Hadassah Medical Organization 36 participants Est. completion 2011-04 1 site
    MASH
    View official trial listing →
  • Withdrawn NCT NCT01260844

    Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.

    Not yet reported Abbott 12 participants
    Other conditions: Moderate to Severe Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT01275170

    A Single-Dose Study to Investigate the Pharmacokinetics of MK-7655 in Participants With Impaired Renal Function (MK-7655-005)

    Not yet reported Merck Sharp & Dohme LLC 49 participants Est. completion 2012-03-05 Stand-alone
    Other conditions: Infectious Disease
    View official trial listing →
  • Status unknown NCT NCT01275937

    A Double Blind Study Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy

    Not yet reported Taipei Medical University 65 participants Est. completion 2014-01 1 site
    Other conditions: Upper Gastrointestinal Bleeding
    View official trial listing →
  • Completed NCT NCT01287195

    Oral OKT3 for the Treatment of Active Ulcerative Colitis

    Not yet reported, Not yet reported Brigham and Women's Hospital 6 participants Est. completion 2013-05-02 1 site Stand-alone
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Terminated NCT NCT01290380

    A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies

    Not yet reported Novartis Pharmaceuticals 54 participants 2 sites Stand-alone
    Other conditions: Solid Tumor Malignancies
    View official trial listing →
  • Completed NCT NCT01323465

    Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex

    Not yet reported Jazz Pharmaceuticals 36 participants Est. completion 2008-03 1 site Stand-alone
    Other conditions: Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4, Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4, Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19 Inhibitor
    View official trial listing →
  • Status unknown NCT NCT01335334

    H. Pylori Eradication Using Pyklear in Adults in El Paso, Texas: a Pilot Study

    Not yet reported The University of Texas Health Science Center, Houston 50 participants Est. completion 2011-08 1 site
    Other conditions: H. Pylori Infection
    View official trial listing →
  • Completed NCT NCT01338077

    Efficacy and Safety of Sodium Alginate Oral Suspension to Treat Non-erosive Gastro-esophageal Reflux Disease

    Not yet reported Chang Gung Memorial Hospital 195 participants Est. completion 2012-01 1 site
    Other conditions: Gastroesophageal Reflux Disease, Heartburn
    View official trial listing →
  • Completed NCT NCT01341600

    Clopidogrel Pharmacogenetics (PGX) Bench to Bedside

    Not yet reported University of Maryland, Baltimore 18 participants Est. completion 2011-05 1 site Stand-alone
    Other conditions: Metabolism of Clopidogrel
    View official trial listing →
  • Completed NCT NCT01349413

    BRAVO Study for Functional Dyspepsia

    Not yet reported Chinese University of Hong Kong 130 participants Est. completion 2018-07-19 1 site
    Other conditions: Dyspepsia, Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT01370538

    Efficacy of Esomeprazole in Patients With Frequent Heartburn

    Not yet reported AstraZeneca 341 participants Est. completion 2011-10 10 sites
    Other conditions: Heartburn
    View official trial listing →
  • Completed NCT NCT01392755

    A Study to Evaluate The Effects of Two Different Meal Types, Omeprazole And Ranitidine On Danoprevir Pharmacokinetics When Coadministered With Ritonavir in Healthy Volunteers

    Not yet reported Hoffmann-La Roche 32 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Terminated NCT NCT01408849

    Use of Maytenus Ilicifolia in the Treatment of Dyspepsia

    Not yet reported Casa Espirita Terra de Ismael 4 participants Est. completion 2016-01 1 site
    Other conditions: Dyspepsia
    View official trial listing →
  • Completed NCT NCT01456728

    Lactobacillus Reuteri ProGastria in Helicobacter Pylori-infected Adult Subjects on Proton Pump Inhibitors

    Not yet reported St Marina University Hospital, Varna, Bulgaria 56 participants Est. completion 2013-09 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01458990

    Proton Pump Inhibitors and Dysbiosis in Cirrhosis

    Not yet reported Hunter Holmes Mcguire Veteran Affairs Medical Center 60 participants Est. completion 2018-02 1 site Stand-alone
    Other conditions: Cirrhosis, Healthy
    View official trial listing →
  • Status unknown NCT NCT01464060

    14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication

    Not yet reported Infante, Javier Molina, M.D. 400 participants Est. completion 2013-01 4 sites Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01470690

    Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO)

    Not yet reported Radboud University Medical Center 24 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: HCV Infections, Gastric Acid-related Disorders
    View official trial listing →
  • Completed NCT NCT01473173

    Safety, Tolerability, PK, PD of Escalating Single and Multiple Oral Doses of CJ-12420 in Healthy Male Subjects

    Not yet reported HK inno.N Corporation 59 participants Est. completion 2012-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01494402

    Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects

    Not yet reported AstraZeneca 77 participants Est. completion 2012-03 1 site
    Other conditions: Bioequivalence Study
    View official trial listing →
  • Completed NCT NCT01499368

    A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients

    Not yet reported Boryung Pharmaceutical Co., Ltd 495 participants Est. completion 2012-11
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Completed NCT NCT01507792

    Iron Repletion in Chronic Cough and Iron Deficiency

    Not yet reported University of Turin, Italy 22 participants Est. completion 2011-01 1 site
    Other conditions: Cough, Laryngeal Disease, Bronchial Disease, Iron Deficiency
    View official trial listing →
  • Completed NCT NCT01544114

    A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA)

    Not yet reported Amgen 46 participants Est. completion 2015-02 17 sites
    Other conditions: Juvenile Idiopathic Arthritis (JIA)
    View official trial listing →
  • Completed NCT NCT01549574

    Drug Drug Interaction Study Of Crizotinib With Esomeprazole.

    Not yet reported Pfizer 16 participants Est. completion 2012-05 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01562639

    Nexium Capsules RE Maintenance Specific Clinical Experience Investigation

    AstraZeneca 647 participants Est. completion 2014-07 46 sites
    Other conditions: Repeatedly Recurring Esophagitis, Relapsing Reflux Esophagitis
    View official trial listing →
  • Completed NCT NCT01570569

    Development of Minidose Inje Cocktail Method for Simultaneous Evaluating Five Cytochrome P450 Isoforms in Human

    Not yet reported Inje University 26 participants Est. completion 2011-03
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01579539

    The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy

    Not yet reported Medical University of Vienna 18 participants Est. completion 2017-05-18 1 site
    Other conditions: Thyroid-associated Ophthalmopathy, Dry Eye Syndrome
    View official trial listing →
  • Completed NCT NCT01593592

    Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients

    Not yet reported Zagazig University 70 participants 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01595425

    Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects

    Not yet reported AstraZeneca 71 participants Est. completion 2012-06 1 site
    Other conditions: Bioequivalence Study
    View official trial listing →
  • Completed NCT NCT01596647

    Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors

    Not yet reported Novartis Pharmaceuticals 39 participants Est. completion 2014-07 5 sites Stand-alone
    Other conditions: Advanced Solid Tumors, Excluding Breast Cancer
    View official trial listing →
  • Completed NCT NCT01599858

    Effect of Repeated Doses of YF476, Omeprazole and Placebo on Stomach Acidity in Healthy Volunteers

    Not yet reported Trio Medicines Ltd. 49 participants Est. completion 1996-10 1 site
    Other conditions: Reflux Oesophagitis
    View official trial listing →
  • Terminated NCT NCT01643785

    Additive Effect of Endonase on Eradication Rate of Second Line Therapy for HP Infection

    Not yet reported Chuncheon Sacred Heart Hospital 30 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01654549

    Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis

    Not yet reported Tehran University of Medical Sciences 40 participants Est. completion 2012-09 1 site Stand-alone
    Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Completed NCT NCT01657578

    Optimal Dosing of Omeprazole in Neonates

    Not yet reported Assistance Publique - Hôpitaux de Paris 55 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT01661101

    Management of Myocardial Injury After Noncardiac Surgery Trial

    Not yet reported Population Health Research Institute 1754 participants Est. completion 2018-03-01 82 sites Stand-alone
    Other conditions: Myocardial Injury After Noncardiac Surgery (MINS)
    View official trial listing →
  • Completed NCT NCT01694706

    Investigation of Food Effect and Gastric ph Increase on the Bioavailability of Faldapravir

    Not yet reported Boehringer Ingelheim 15 participants Est. completion 2012-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01710800

    Twenty-Four Hour Combined Multi-Channel Impedance and pH Ambulatory Monitoring: Impedance Reflux Episodes of Patients On and Off Proton Pump Inhibitor Therapy

    Not yet reported Walter Reed National Military Medical Center 41 participants Est. completion 2012-09
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT01710995

    A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions

    Not yet reported Norgine 20 participants Est. completion 2011-02 1 site
    Other conditions: Acid Reflux, Gastro Oesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT01711320

    Effect of Omeprazole on Metformin

    Not yet reported Xijing Hospital 20 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01723059

    Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection

    Not yet reported Dallas VA Medical Center 184 participants Est. completion 2013-01 1 site
    Other conditions: Helicobacter Infection
    View official trial listing →
  • Status unknown NCT NCT01735227

    Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN)

    Not yet reported Yaling Han 620 participants Est. completion 2013-10 2 sites Stand-alone
    Other conditions: Acute Coronary Syndromes
    View official trial listing →
  • Completed NCT NCT01750437

    Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)

    Not yet reported Yuhan Corporation 149 participants Est. completion 2014-04 10 sites
    Other conditions: Non-erosive Reflux Disease
    View official trial listing →
  • Completed NCT NCT01757275

    High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer

    Not yet reported AstraZeneca 239 participants Est. completion 2014-12 12 sites
    Other conditions: Bleeding Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT01759628

    Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease

    Not yet reported Tehran University of Medical Sciences 100 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Withdrawn NCT NCT01762644

    The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients

    Not yet reported Perle Bioscience, Inc. Est. completion 2016-08 Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01786382

    A Drug Interaction Study of the Effects of PPI-668 on the Pharmacokinetics of Midazolam and Omeprazole

    Not yet reported Presidio Pharmaceuticals, Inc. 24 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Pharmacokinetic Assessments in Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01792700

    Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy

    Not yet reported Seoul National University Bundang Hospital 648 participants Est. completion 2010-12 1 site
    Other conditions: Helicobacter Infections
    View official trial listing →
  • Status unknown NCT NCT01795794

    Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC

    Not yet reported Soroka University Medical Center 12 participants Est. completion 2013-12 Stand-alone
    Other conditions: CDA Type I
    View official trial listing →
  • Completed NCT NCT01820143

    Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety

    Not yet reported Il-Yang Pharm. Co., Ltd. 40 participants Est. completion 2005-04 1 site
    Other conditions: Healthy, Pharmacokinetics, Pharmacodynamics, Ilaprazole
    View official trial listing →
  • Status unknown NCT NCT01822106

    Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD)

    Not yet reported China Medical University Hospital 90 participants 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Withdrawn NCT NCT01824199

    CYP2C19 Genotype Predictor of Gastric Acid Suppression

    Not yet reported Mayo Clinic Est. completion 2016-11 1 site Stand-alone
    Other conditions: Esophagitis
    View official trial listing →
  • Completed NCT NCT01841489

    A Phase 1 Study of Novel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Bioavailability, and Food Effect on GS-9973 Pharmacokinetics

    Not yet reported Gilead Sciences 56 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01844583

    Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib

    Not yet reported Millennium Pharmaceuticals, Inc. 55 participants Est. completion 2016-09-06 7 sites
    Other conditions: Solid Tumors, Lymphoma
    View official trial listing →
  • Completed NCT NCT01854970

    Benefit of Pharyngeal and Oesophageal pH-impedance of Patients With High Suspicion of Laryngopharyngeal Reflux

    Not yet reported University Hospital, Bordeaux 30 participants Est. completion 2015-07 1 site
    Other conditions: Laryngopharyngeal Reflux, Oesophageal pH-impedance
    View official trial listing →
  • Completed NCT NCT01873079

    PPI for Prevention of Post-sphincterotomy Bleeding

    Not yet reported The University of Hong Kong 185 participants Est. completion 2016-06 1 site
    Other conditions: Bleeding, ERCP
    View official trial listing →
  • Completed NCT NCT01874535

    Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy

    Not yet reported Chang Gung Memorial Hospital 408 participants Est. completion 2016-06 1 site
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Completed NCT NCT01876108

    The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease

    Not yet reported Tehran University of Medical Sciences 100 participants Est. completion 2013-07 1 site Stand-alone
    Other conditions: Fatty Liver, Liver Dysfunction, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01901276

    Effects of Gastric Acid on Colonic Microbiome

    Not yet reported Daniel Freedberg, MD 14 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: Clostridium Difficile
    View official trial listing →
  • Completed NCT NCT01907633

    An Observational Study to Assess the Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Users of Proton Pump Inhibitors, and Users of Metoclopramide

    Janssen Research & Development, LLC 15000 participants Est. completion 2013-12
    Substance use disorder
    View official trial listing →
  • Completed NCT NCT01911728

    Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates

    Not yet reported Astellas Pharma Europe B.V. 14 participants Est. completion 2012-02-21 2 sites Stand-alone
    Other conditions: Pharmacokinetics of MDV3100, Castration Resistant Prostate Cancer (CRPC)
    View official trial listing →
  • Completed NCT NCT01921647

    The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects

    Not yet reported Yuhan Corporation 95 participants Est. completion 2013-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01922505

    Eradication Rates of Helicobacter Pylori and Its Affecting Factors

    Seoul National University Bundang Hospital 2500 participants Est. completion 2013-05 1 site
    Other conditions: Helicobacter Infections
    View official trial listing →
  • Completed NCT NCT01925144

    A Study of Baricitinib and Omeprazole in Healthy Participants

    Not yet reported Eli Lilly and Company 30 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01964131

    BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects

    Not yet reported AstraZeneca 34 participants Est. completion 2013-12 2 sites
    Other conditions: Gastric Ulcer, Duodenal Ulcer, Anastomotic Ulcer, Reflux Esophagitis, Etc.
    View official trial listing →
  • Completed NCT NCT01983774

    Effect of Proton Pump Inhibitors on CF Pulmonary Exacerbations

    Not yet reported Columbia University 21 participants Est. completion 2011-08 1 site
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT02013427

    Placebo In Chronic Back Pain - Double-Blind Randomized Control Trial

    Not yet reported Northwestern University 82 participants Est. completion 2016-05 1 site
    Other conditions: Chronic Low Back Pain
    View official trial listing →
  • Withdrawn NCT NCT02013453

    A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer

    Not yet reported University of Michigan Rogel Cancer Center 1 site Stand-alone
    Other conditions: Cancer of Head and Neck
    View official trial listing →
  • Status unknown NCT NCT02028234

    "Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER-

    Not yet reported University of Roma La Sapienza 150 participants Est. completion 2016-04 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02028663

    Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis

    Not yet reported HK inno.N Corporation 206 participants Est. completion 2014-05 1 site
    Other conditions: Erosive Esophagitis, GERD
    View official trial listing →
  • Completed NCT NCT02037477

    Phase 3 Study to Evaluate the Acid-Inhibitory Effect of Multiple Oral Doses of Vonoprazan (TAK-438)

    Not yet reported Takeda 20 participants Est. completion 2014-03 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Withdrawn NCT NCT02039869

    Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD)

    Not yet reported Virginia Commonwealth University 3 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease, Non Erosive Reflux Disease, Dyspepsia
    View official trial listing →
  • Status unknown NCT NCT02071316

    The Use of Hexacapron in Upper Gastrointestinal Bleeding

    Not yet reported Shaare Zedek Medical Center 300 participants Est. completion 2015-04 1 site
    Other conditions: Upper Gastrointestinal Bleeding, Hexacapron, Hemostasis, Rebleeding, Mortality
    View official trial listing →
  • Completed NCT NCT02141698

    Safety, Tolerability, and Pharmacokinetics of TAK-438 in Healthy Western Male Subjects, Preliminary Food Effect Analysis, and an Ethnic Comparison With Japanese Subjects

    Not yet reported Takeda 73 participants Est. completion 2008-02
    Other conditions: Dose Finding Study
    View official trial listing →
  • Completed NCT NCT02157376

    Stress Ulcer Prophylaxis of Intravenous Esomeprazole in Chinese Seriously Ill Patients

    Not yet reported AstraZeneca 343 participants Est. completion 2016-02 15 sites
    Other conditions: Stress Ulcer Prophylaxis
    View official trial listing →
  • Completed NCT NCT02182336

    Effects of BI 201335 NA on Cytochrome P450 and P-glycoprotein Activity Using a Probe Drug Cocktail in Healthy Volunteers

    Not yet reported Boehringer Ingelheim 23 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02191358

    YouScript IMPACT Registry

    Genelex Corporation 800 participants Est. completion 2015-08 7 sites
    Other conditions: Adverse Drug Events, Adverse Drug Reactions, Drug Interaction Potentiation, Drug Metabolism, Poor, CYP2D6-RELATED, Drug Metabolism, Poor, CYP2C19-RELATED, Cytochrome P450 Enzyme Deficiency, Cytochrome P450 CYP2D6 Enzyme Deficiency, Cytochrome P450 CYP2C9 Enzyme Deficiency, Cytochrome P450 CYP2C19 Enzyme Deficiency, Cytochrome P450 CYP3A Enzyme Deficiency, Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant, Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant, Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
    View official trial listing →
  • Completed NCT NCT02197143

    A Comparison of Efficacy of Intravenous Esomeprazole and Ranitidine Treatment of Dyspeptic Pain

    Not yet reported Pamukkale University 286 participants Est. completion 2014-07 1 site
    Other conditions: Dyspepsia
    View official trial listing →
  • Completed NCT NCT02199002

    Acid Pocket: Position and Aspiration

    Not yet reported KU Leuven 70 participants Est. completion 2017-12-31 1 site
    Other conditions: GERD - PPI Responders, GERD - PPI Non-responders, Barrett Esophagus, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02205489

    Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADA

    Not yet reported Genzyme, a Sanofi Company 58 participants Est. completion 2016-04 20 sites
    Other conditions: Relapsing-remitting Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT02226783

    D5611C00003 - Food Interaction Study With AZD1722 Tablet in Healthy Subjects

    Not yet reported Ardelyx 37 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Healthy Volunteers Food Interaction Study
    View official trial listing →
  • Completed NCT NCT02249871

    Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects

    Not yet reported Novo Nordisk A/S 54 participants Est. completion 2015-04-01 1 site Added to GLP-1
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT02249936

    A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations

    Not yet reported Ardelyx 18 participants Est. completion 2013-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02253875

    Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult Volunteers

    Not yet reported Boehringer Ingelheim 15 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02254148

    The Effect of BI 187004 on the Pharmacokinetics of Cytochrome P450 Substrates (Caffeine, Warfarin, Omeprazole, Metoprolol and Midazolam) and a P Glycoprotein Substrate (Digoxin)

    Not yet reported Boehringer Ingelheim 24 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT02262169

    DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers

    Not yet reported Dexa Medica Group 32 participants Est. completion 2019-03 1 site Stand-alone
    Other conditions: Non-Bleeding Peptic Ulcers
    View official trial listing →
  • Terminated NCT NCT02272868

    Fecal Microbial Transplant in Pediatric Crohn's Disease

    Not yet reported, Not yet reported Seattle Children's Hospital 7 participants Est. completion 2016-10-01 1 site Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Status unknown NCT NCT02288078

    Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)

    Not yet reported Clinical Research Support Center Kyush 74 participants Est. completion 2016-09 1 site
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT02291666

    Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic Subjects

    Not yet reported Centre hospitalier de l'Université de Montréal (CHUM) 73 participants Est. completion 2019-07 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02296021

    Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy

    Not yet reported Xijing Hospital of Digestive Diseases 612 participants Est. completion 2015-09 1 site
    Other conditions: Gastritis, Peptic Ulcer, Dyspepsia
    View official trial listing →
  • Status unknown NCT NCT02307305

    Does Duloxetine Reduce Chronic Pain After Total Knee Arthroplasty?

    Not yet reported Hanyang University Seoul Hospital 168 participants Est. completion 2016-12 1 site
    Other conditions: Neuropathic Pain
    View official trial listing →
  • Withdrawn NCT NCT02345304

    Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and Digoxin

    Not yet reported Boehringer Ingelheim Est. completion 2015-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02355236

    Gastro-protective Effect and Pain Relief Effect of Naxozol Compared to Celecoxib in Patients With Osteoarthritis

    Not yet reported Severance Hospital 106 participants Est. completion 2015-12 10 sites
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT02361619

    Dabigatran in an Interaction Probe Drug Cocktail

    Not yet reported Turku University Hospital 16 participants Est. completion 2017-06 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02367937

    PRC-4016 (Icosabutate) Phase I Drug-drug Interaction Study

    Not yet reported Pronova BioPharma 16 participants Est. completion 2014-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02394340

    Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris

    Not yet reported Bausch & Lomb Incorporated 20 participants Est. completion 2015-04-01 1 site Stand-alone
    Other conditions: Tinea Pedis, Tinea Cruris
    View official trial listing →
  • Completed NCT NCT02395458

    Efficacy on Helicobacter Pylori Eradication With Two Antibiotic Regimens

    Not yet reported Coordinación de Investigación en Salud, Mexico 142 participants Est. completion 2015-02 Stand-alone
    Other conditions: Helicobacter Infections
    View official trial listing →
  • Status unknown NCT NCT02422706

    Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori

    Not yet reported Sherief Abd-Elsalam 120 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Helicobacter-associated Gastritis
    View official trial listing →
  • Completed NCT NCT02453022

    A 5-Period, Single Dose, Phase 1 Study in Healthy Elderly Subjects to Assess Relative Bioavailability and Food Effect of Two Oral Formulations of GSK1325756 (Free Base vs HBr Salt) and Food Effect on the HBr Formulation When Given With Omeprazole

    Not yet reported GlaxoSmithKline 18 participants Est. completion 2015-07-31 1 site Stand-alone
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02456012

    Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients

    Not yet reported Hsiu-Chi Cheng 268 participants Est. completion 2020-12-31 1 site
    Other conditions: Peptic Ulcer Hemorrhage
    View official trial listing →
  • Status unknown NCT NCT02472600

    Eradication of Antibiotic-resistant Bacteria Through Antibiotics and Fecal Bacteriotherapy

    Not yet reported Stephen Harbarth 39 participants Est. completion 2018-03 4 sites
    Other conditions: Intestinal Colonization With Multidrug-resistant Bacteria
    View official trial listing →
  • Completed NCT NCT02473627

    A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS

    Not yet reported Daiichi Sankyo 18 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02473640

    A Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Adults With an Ileostomy

    Not yet reported, Not yet reported Theriva Biologics, Inc. 15 participants Est. completion 2016-04 2 sites
    Other conditions: Healthy Volunteers With Ileostomy
    View official trial listing →
  • Terminated NCT NCT02475369

    Pancreatic Enzyme Supplementation for Celiac Disease

    Not yet reported Beth Israel Deaconess Medical Center 21 participants Est. completion 2019-12 1 site
    Other conditions: Celiac Disease
    View official trial listing →
  • Status unknown NCT NCT02476097

    PROGRESSive Withdrawal Esomeprazole and Acid-related Symptoms

    Not yet reported Victoria Rollason 58 participants Est. completion 2023-12 2 sites
    Other conditions: Stomach Diseases
    View official trial listing →
  • Completed NCT NCT02479581

    The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS)Applied on Cardiac Surgery With Cardiopulmonary Bypass

    Not yet reported Xiangya Hospital of Central South University 226 participants Est. completion 2017-05 1 site
    Other conditions: Valvular Heart Disease
    View official trial listing →
  • Completed NCT NCT02492776

    A Multiple-Dose Pharmacokinetics Study of Two Gefapixant (AF-219/MK-7264) Formulations

    Not yet reported Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 14 participants Est. completion 2015-08-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02500641

    Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout

    Not yet reported Menarini International Operations Luxembourg SA 196 participants Est. completion 2017-05-10 26 sites Stand-alone
    Other conditions: Gout
    View official trial listing →
  • Completed NCT NCT02504554

    Beneficial Bacteria Treatment for Autism

    Not yet reported, Not yet reported Arizona State University 18 participants Est. completion 2016-04
    Other conditions: Gastrointestinal Problems, Autism Spectrum Disorders
    View official trial listing →
  • Withdrawn NCT NCT02530879

    Comparison of Voice Therapy and Antireflex Therapy in LPR

    Not yet reported Temple University Est. completion 2018-01 2 sites
    Other conditions: Laryngopharyngeal Reflux
    View official trial listing →
  • Completed NCT NCT02536989

    Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot

    Not yet reported Far Eastern Memorial Hospital 40 participants Est. completion 2012-07 1 site Stand-alone
    Other conditions: Peptic Ulcer, Hemorrhage
    View official trial listing →
  • Completed NCT NCT02547012

    Comparison of Two Rescue Therapies for Helicobacter Pylori Infection

    Not yet reported Kaohsiung Veterans General Hospital. 51 participants Est. completion 2017-10 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT02552537

    iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions

    Not yet reported University of Zurich 44 participants Est. completion 2017-03 2 sites
    Other conditions: Food Allergy
    View official trial listing →
  • Completed NCT NCT02567682

    Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects

    Not yet reported Global Blood Therapeutics 24 participants Est. completion 2016-05 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Status unknown NCT NCT02584751

    GERD and Anti-Reflux Therapy Between Able-bodied and SCI Individuals

    Not yet reported James J. Peters Veterans Affairs Medical Center 110 participants 1 site Stand-alone
    Other conditions: Gastro Esophageal Reflux Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT02592317

    A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

    Not yet reported Aragon Pharmaceuticals, Inc. 23 participants Est. completion 2027-12-31 3 sites Stand-alone
    Other conditions: Prostatic Neoplasms, Castration-Resistant
    View official trial listing →
  • Completed NCT NCT02593448

    Influence of Cardiopulmonary Bypass, and Sevoflurane or Propofol Anesthesia, on Tissue Oxygen Saturation.

    Not yet reported Medical University of Gdansk 64 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: NIR Spectroscopy
    View official trial listing →
  • Completed NCT NCT02595372

    Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy

    Not yet reported Kathy Miller 42 participants Est. completion 2021-03-01 9 sites Stand-alone
    Other conditions: Cancer of the Breast
    View official trial listing →
  • Completed NCT NCT02596620

    Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication

    Not yet reported Chang Gung Memorial Hospital 164 participants Est. completion 2015-11
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT02623816

    Symptom Control Satisfaction With Proton Pump Inhibitor Regimen

    Not yet reported MetroHealth Medical Center 64 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Heartburn
    View official trial listing →
  • Completed NCT NCT02637557

    A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)

    Not yet reported Ironwood Pharmaceuticals, Inc. 282 participants Est. completion 2017-04-26 62 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT02647086

    Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)

    Not yet reported Regeneron Pharmaceuticals 14 participants Est. completion 2016-07 5 sites Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT02659683

    Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR Capsules Under Fasting Conditions

    Not yet reported Torrent Pharmaceuticals Limited 54 participants Est. completion 2011-05
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT02663492

    Transcutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer Patients

    Not yet reported Tongji University 300 participants Est. completion 2016-12 1 site
    Other conditions: Non-Small Cell Lung Cancer, Lung Cancer
    View official trial listing →
  • Completed NCT NCT02670642

    Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD

    Not yet reported AstraZeneca 877 participants Est. completion 2002-11 60 sites
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT02708355

    Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment

    Not yet reported Pfizer 55 participants Est. completion 2016-04 2 sites
    Other conditions: Heartburn
    View official trial listing →
  • Completed NCT NCT02730026

    Comparison of the Clinical Efficacy of Ketoprofen, Associated or Not With Omeprazole in Lower Third Molar Removal

    Not yet reported Luis Fernando Simoneti 50 participants Est. completion 2017-03 1 site Stand-alone
    Other conditions: Pain, Other Surgical Procedures
    View official trial listing →
  • Completed NCT NCT02740712

    Pharmacokinetic Drug-Drug Interaction Study of Rucaparib

    Not yet reported pharmaand GmbH 17 participants Est. completion 2019-09 3 sites
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT02743949

    Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)

    Not yet reported Takeda 256 participants Est. completion 2018-10-12 39 sites
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT02757144

    Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers

    Not yet reported Daewoong Pharmaceutical Co. LTD. 120 participants Est. completion 2017-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT02760615

    Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

    Not yet reported Takeda Est. completion 2020-08-01 2 sites Stand-alone
    Other conditions: Colitis, Ulcerative, Crohn Disease
    View official trial listing →
  • Completed NCT NCT02772601

    This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis

    Not yet reported AbbVie 21 participants Est. completion 2017-09-22 1 site Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02783040

    Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin

    Not yet reported Boehringer Ingelheim 13 participants Est. completion 2015-10-30 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02789527

    Human Genomic Population Structure and Phenotype-genotype Variation in ADME Genes in Four Populations

    Not yet reported Estella S. Poloni 367 participants Est. completion 2017-04 4 sites Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02794844

    Implementation of PPI Medication PGX Testing

    Not yet reported Nemours Children's Clinic 28 participants Est. completion 2018-08-31 1 site
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT02803216

    Traditional Chinese Medicine Combined With Standard Triple Region for Eradication of Helicobacter Pylori

    Not yet reported, Not yet reported Xiyuan Hospital of China Academy of Chinese Medical Sciences 576 participants Est. completion 2016-04 Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT02884713

    Levofloxacin-Doxycycline for Helicobacter Pylori Eradication in Saudi Arabia

    Not yet reported King Faisal Specialist Hospital & Research Center 55 participants Est. completion 2014-04
    Other conditions: GASTRITIS
    View official trial listing →
  • Completed NCT NCT02893709

    Factors Influencing the Human Gut Microbiome Profile in Multi-ethnic Groups of the Singapore Community (FAMES)

    Not yet reported Changi General Hospital 36 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT02922699

    Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases

    Not yet reported Dr. Reddy's Laboratories Limited 120 participants Est. completion 2013-06 Stand-alone
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT02922933

    A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects

    Not yet reported Syndax Pharmaceuticals 66 participants Est. completion 2017-05-08 2 sites
    Other conditions: Volunteers, Healthy Volunteers, Human Volunteers, Normal Volunteers
    View official trial listing →
  • Completed NCT NCT02957474

    A Study to Evaluate the Effect of Food, Formulation Strength, and a Proton Pump Inhibitor on GED 0301 Pharmacokinetics in Healthy Adult Subjects

    Not yet reported Celgene 18 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02986334

    Placebo In Chronic Back Pain (Phase 2)

    Not yet reported Apkar Apkarian 94 participants Est. completion 2018-06 1 site
    Other conditions: Chronic Low Back Pain
    View official trial listing →
  • Completed NCT NCT03006874

    Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis

    Not yet reported HK inno.N Corporation 302 participants Est. completion 2017-03-24 1 site
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Completed NCT NCT03028103

    Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients

    Not yet reported Epizyme, Inc. 32 participants Est. completion 2019-11-29 3 sites Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle Cell Lymphoma, Advanced Solid Tumor, Marginal Zone Lymphoma
    View official trial listing →
  • Status unknown NCT NCT03040817

    Cooperative Group for Clinical Research in G-POEM (POP), Jiangsu, China

    Not yet reported Zhongda Hospital 50 participants Est. completion 2019-12-16 1 site
    Other conditions: Gastric Peroral Endoscopic Pyloromyotomy (G-POEM)
    View official trial listing →
  • Completed NCT NCT03058419

    A Study to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail in Healthy Subjects

    Not yet reported Janssen Research & Development, LLC 16 participants Est. completion 2017-05-15 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT03059303

    Study to Assess the Relative Bioavailability of Fixed-Dose Combination (FDC) Tablet (Simeprevir, Odalasvir and AL-335) Compared With Single Agents Administered Together, and to Assess the Effect of Multiple-Dose Lansoprazole or Omeprazole on Single-Dose Pharmacokinetics of SMV, ODV, and AL-335 (FDC)

    Not yet reported Janssen Research & Development, LLC 72 participants Est. completion 2017-04-24 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03086070

    Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis

    Not yet reported Children's Hospital Srebrnjak 60 participants Est. completion 2010-06-30 Stand-alone
    Other conditions: Laryngopharyngeal Reflux, Chronic Rhinosinusitis (Diagnosis)
    View official trial listing →
  • Completed NCT NCT03100838

    Drug Interaction With Proton Pump Inhibitors for Nifedipine ER Tablets

    Not yet reported Food and Drug Administration (FDA) 64 participants Est. completion 2018-04-06 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03105375

    Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of X842 in Human: A Single/Multiple Ascending Dose Study

    Not yet reported Cinclus Pharma Holding AB 39 participants Est. completion 2017-10-12 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03131973

    Effects of Concomitant Administration of BMS-986195 on Methotrexate, Caffeine, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin

    Not yet reported Bristol-Myers Squibb 26 participants Est. completion 2017-11-10 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT03137134

    A Study to Evaluate the Effects of Food and Esomeprazole on the Pharmacokinetics of Crizotinib in a Coated Microsphere Formulation.

    Not yet reported Pfizer 18 participants Est. completion 2017-10-17 1 site
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT03146325

    Helicobacter Pylori and Body Iron in Adults

    Not yet reported The University of Texas Health Science Center, Houston Est. completion 2016-08 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03163680

    Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers

    Damascus Hospital 295 participants Est. completion 2018-06-04 1 site
    Other conditions: Gastroduodenal Ulcer, Marginal Ulcer, Peptic Ulcer Hemorrhage
    View official trial listing →
  • Completed NCT NCT03184324

    Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)

    Not yet reported Daewoong Pharmaceutical Co. LTD. 211 participants Est. completion 2018-04-18 1 site
    Other conditions: Erosive Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT03195946

    Effects of Repeated Doses of Lu AF35700 on Drug Metabolizing Enzymes

    Not yet reported H. Lundbeck A/S 24 participants Est. completion 2018-01-03 1 site Stand-alone
    Other conditions: Drug Reactions
    View official trial listing →
  • Status unknown NCT NCT03208426

    Sequential Versus Quadruple Therapy in the Second-line Treatment

    Not yet reported National Taiwan University Hospital 240 participants Est. completion 2020-12-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT03220542

    The Effect of Broccoli Sprout Extract and Probiotics for Eradication of Helicobacter Pylori

    Not yet reported Kyunghee University Medical Center 360 participants Est. completion 2019-12-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03238534

    Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS

    Not yet reported Aboca Spa Societa' Agricola 275 participants Est. completion 2021-09-03 12 sites Stand-alone
    Other conditions: GERD, EPS
    View official trial listing →
  • Status unknown NCT NCT03315676

    Efficacy of Proton Pump Inhibitors in Gastrointestinal Erosions and/or Ulcers

    Not yet reported Shinshu University 124 participants Est. completion 2025-09-04 1 site
    Other conditions: Gastrointestinal Erosions and/or Ulcers
    View official trial listing →
  • Completed NCT NCT03327051

    Gastric Acid Suppression and Probiotic Colonization

    Not yet reported Stanford University 39 participants Est. completion 2018-12-30 1 site
    Other conditions: Probiotics
    View official trial listing →
  • Status unknown NCT NCT03347513

    Eradication of H-pylori in Pregnancy and Its Effect on Iron Replacement Therapy?

    Not yet reported Kasr El Aini Hospital 150 participants Est. completion 2019-05 1 site Stand-alone
    Other conditions: Pregnancy Complications, Anemia, Iron Deficiency, H Pylori Infection
    View official trial listing →
  • Terminated NCT NCT03358706

    A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

    Not yet reported Janssen Research & Development, LLC 28 participants Est. completion 2021-11-22 16 sites Stand-alone
    Other conditions: Crohn Disease, Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT03362281

    Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients

    Not yet reported Livzon Pharmaceutical Group Inc. 540 participants Est. completion 2015-04
    Other conditions: Peptic Ulcer Hemorrhage
    View official trial listing →
  • Terminated NCT NCT03367195

    Efficacy and Safety of DLBS2411 in the Management of GERD

    Not yet reported Dexa Medica Group 32 participants Est. completion 2020-09-09 5 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Status unknown NCT NCT03372850

    Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations

    Not yet reported Hanmi Pharmaceutical Company Limited 96 participants Est. completion 2018-06-15 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03378960

    Study to Compare the Bioavailability of Omeprazole 20 mg Before and After Undergoing Surgery for Morbid Obesity

    Not yet reported Emilio Vargas Castrillón 43 participants Est. completion 2016-02-29 1 site
    Other conditions: Bariatric Surgery Candidate
    View official trial listing →
  • Completed NCT NCT03383003

    Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy

    Not yet reported Chang Gung Memorial Hospital 240 participants Est. completion 2018-05-01 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03405584

    High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment

    Not yet reported Shanghai Jiao Tong University School of Medicine 160 participants Est. completion 2018-11-02 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT03428568

    Safety Trial of Herbal Melanin in Gastritis Patients

    Not yet reported King Abdullah International Medical Research Center 132 participants Est. completion 2020-03 Stand-alone
    Other conditions: Acid Dyspepsia, Gastritis
    View official trial listing →
  • Completed NCT NCT03444402

    A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects

    Not yet reported Chong Kun Dang Pharmaceutical 18 participants Est. completion 2018-05-04 1 site
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT03444831

    Buspirone Plus Omeprazole for Functional Dyspepsia

    Not yet reported Isfahan University of Medical Sciences 70 participants Est. completion 2017-04-01 Stand-alone
    Other conditions: Dyspepsia
    View official trial listing →
  • Completed NCT NCT03452865

    Esomeprazole to Reduce Organ Failure in Sepsis

    Not yet reported Università Vita-Salute San Raffaele 300 participants Est. completion 2023-08-21 17 sites
    Other conditions: Sepsis, Septic Shock
    View official trial listing →
  • Completed NCT NCT03457597

    Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s

    Not yet reported Corcept Therapeutics 27 participants Est. completion 2018-04-28 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT03491995

    A Unique Regimen for Treatment of Helicobacter Pylori Infection

    Not yet reported Sherief Abd-Elsalam 600 participants Est. completion 2023-04-01 1 site Stand-alone
    Other conditions: Helicobacter Infections
    View official trial listing →
  • Completed NCT NCT03505853

    A Study to Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP)

    Not yet reported Alnylam Pharmaceuticals 10 participants Est. completion 2019-01-10 1 site Stand-alone
    Other conditions: Acute Intermittent Porphyria (AIP), Acute Hepatic Porphyria (AHP), Porphyria, Acute Intermittent, Acute Porphyria
    View official trial listing →
  • Completed NCT NCT03531762

    Effect of a Proton Pump Inhibitor on the PK of Tepotinib

    Not yet reported Merck KGaA, Darmstadt, Germany 12 participants Est. completion 2018-07-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03553563

    A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer

    Not yet reported AstraZeneca 50 participants Est. completion 2022-12-27 15 sites
    Other conditions: Reflux Esophagitis, Gastric Ulcer, Duodenal Ulcer
    View official trial listing →
  • Completed NCT NCT03563287

    Effects of LRYGB on Pharmacokinetics of Nine CYP Probe Drugs

    Not yet reported University of Eastern Finland 13 participants Est. completion 2014-12-10 1 site Stand-alone
    Other conditions: Obesity, Morbid, Bariatric Surgery Candidate
    View official trial listing →
  • Completed NCT NCT03592069

    Concomitant Versus Hybrid Regimen for H. Pylori Eradication

    Not yet reported Alexandra Hospital, Athens, Greece 345 participants Est. completion 2021-01-31 1 site
    Other conditions: H.Pylori Infection, H.Pylori Gastrointestinal Disease, H. Pylori Associated Phlegmonous Gastritis
    View official trial listing →
  • Completed NCT NCT03598738

    The Effect of Esomeprazole on Type 2 Diabetes

    Not yet reported Baskent University Ankara Hospital 32 participants Est. completion 2017-12-01
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03600974

    A New System for GERD Diagnosis and Treatment

    Capital Medical University 200 participants Est. completion 2021-07-01
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT03615677

    Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis

    Not yet reported Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. 261 participants Est. completion 2019-10-18 1 site
    Other conditions: Erosive Esophagitis (EE)
    View official trial listing →
  • Status unknown NCT NCT03619408

    Management of Esophagitis Following Repair of Esophageal Atresia

    Boston Children's Hospital 50 participants Est. completion 2025-07 2 sites
    Other conditions: Esophageal Atresia, Esophagitis
    View official trial listing →
  • Completed NCT NCT03650543

    Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication

    Not yet reported Javeriana University 133 participants Est. completion 2015-08-08 Stand-alone
    Other conditions: CYP2C19 Polymorphism, H.Pylori Infection, Therapy
    View official trial listing →
  • Completed NCT NCT03708211

    A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors

    Not yet reported Millennium Pharmaceuticals, Inc. 20 participants Est. completion 2019-12-03 4 sites
    Other conditions: Neoplasms, Advanced Solid
    View official trial listing →
  • Completed NCT NCT03709355

    Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs

    Not yet reported Viriom 56 participants Est. completion 2019-09-06 1 site Stand-alone
    Other conditions: HIV-1-infection
    View official trial listing →
  • Status unknown NCT NCT03724838

    Esomeprazole With Sildenafil Citrate in Women With Early-onset Preeclampsia

    Not yet reported Aswan University Hospital 180 participants Est. completion 2022-01-01 1 site
    Other conditions: Preeclampsia
    View official trial listing →
  • Status unknown NCT NCT03730766

    Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in Adults

    Not yet reported Shanghai Jiao Tong University School of Medicine 60 participants Est. completion 2018-11-20 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03736369

    Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)

    Not yet reported Daewoong Pharmaceutical Co. LTD. 263 participants Est. completion 2019-08-07 1 site
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Completed NCT NCT03757650

    THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY

    Not yet reported Fatih Sultan Mehmet Training and Research Hospital 3 participants Est. completion 2021-02-01 1 site
    Other conditions: Helicobacter Pylori Infection, Obesity, Morbid
    View official trial listing →
  • Completed NCT NCT03814642

    Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male Participants

    Not yet reported HK inno.N Corporation 25 participants Est. completion 2019-07-22 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03849690

    A Trial to Evaluate the Effect of the Proton Pump Inhibitor Esomeprazole on the Single-dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants

    Not yet reported Millennium Pharmaceuticals, Inc. 12 participants Est. completion 2019-04-15 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03866434

    Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of SPD422 (Anagrelide Hydrochloride) in Healthy Adult Participants

    Not yet reported Shire 20 participants Est. completion 2019-04-10 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Withdrawn NCT NCT03950037

    SANCC: Clinical Trial Early Intervention

    Not yet reported Oregon Health and Science University Est. completion 2023-04 Stand-alone
    Other conditions: Subarachnoid Neurocysticercosis
    View official trial listing →
  • Completed NCT NCT03967886

    Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients

    Not yet reported Yooyoung Pharmaceutical Co., Ltd. 170 participants Est. completion 2020-05-27 1 site
    Other conditions: Non-erosive Reflux Disease
    View official trial listing →
  • Completed NCT NCT03979989

    Drug-drug Interaction Study to Evaluate the Effect of Omeprazole on CG5503 (Tapentadol)

    Not yet reported Grünenthal GmbH 32 participants Est. completion 2005-11-16 1 site Stand-alone
    Other conditions: Pharmacokinetic
    View official trial listing →
  • Completed NCT NCT03980756

    A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole

    Not yet reported Addpharma Inc. 88 participants Est. completion 2020-06-18 1 site
    Other conditions: Gastritis
    View official trial listing →
  • Completed NCT NCT04024527

    High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment

    Not yet reported Shanghai Jiao Tong University School of Medicine 306 participants Est. completion 2021-05-24 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT04034641

    Effect of Probiotics on Helicobacter Pylori Eradication

    Not yet reported Hangzhou Grand Biologic Pharmaceutical, Inc. 238 participants Est. completion 2021-12-31 2 sites
    Other conditions: Helicobacter Pylori Eradication
    View official trial listing →
  • Terminated NCT NCT04051853

    Sorafenib PK in Patients With Advanced HCC and Child-Pugh B

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 5 participants Est. completion 2017-03 1 site Stand-alone
    Other conditions: BCLC Stage C HCC, CP-B Liver Cirrhosis
    View official trial listing →
  • Not yet recruiting NCT NCT04069286

    EFFICACY OF ORAL AROEIRA (Schinus Terebinthifolia Raddi) COMPARED TO OMEPRAZOLE IN DYSPEPPSIA

    Not yet reported Infan Industria Quimica Farmaceutica Nacional 474 participants Est. completion 2027-03
    Other conditions: Dyspepsia
    View official trial listing →
  • Completed NCT NCT04080726

    Efficacy and Safety of HIP1601 Capsule

    Not yet reported Hanmi Pharmaceutical Company Limited 213 participants Est. completion 2019-12-03 1 site
    Other conditions: Erosive Gastroesophageal Reflux Disease
    View official trial listing →
  • Status unknown NCT NCT04090021

    Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.

    Not yet reported Konstantopoulio-Patission General Hospital of Nea Ionia 304 participants Est. completion 2020-02-28 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT04108676

    Effect of Omeprazole on PK of Fluzoparib in Healthy Male Subjects

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 16 participants Est. completion 2019-11-18 1 site Stand-alone
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Status unknown NCT NCT04130659

    Study to Evaluate the Performance and Safety of the MARIAL® in Association With PPI Versus PPI Alone

    Not yet reported Nekkar Lab Srl 110 participants Est. completion 2025-01-31 5 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT04138836

    Assess the Drug Interactions of BBT-877 and Midazolam, Itraconazole, and Esomeprazole in Healthy Adult Subjects

    Not yet reported Bridge Biotherapeutics, Inc. 48 participants Est. completion 2019-11-04 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT04142762

    A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults

    Not yet reported Assembly Biosciences 80 participants Est. completion 2020-01-29 1 site
    Other conditions: Chronic Hepatitis B
    View official trial listing →
  • Status unknown NCT NCT04170270

    Oral Omeprazole in Bleeding Peptic Ulcer

    Not yet reported Assiut University 100 participants Est. completion 2021-01 Stand-alone
    Other conditions: Bleeding Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT04199624

    Assessment of Gastric pH Changes Induced by Ascorbic Acid Tablets

    Not yet reported Indiana University 11 participants Est. completion 2023-06-07 1 site Stand-alone
    Other conditions: Hypochlorhydria
    View official trial listing →
  • Completed NCT NCT04246762

    Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19 and CYP3A4

    Not yet reported R-Pharm International, LLC 17 participants Est. completion 2022-10-26 2 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT04254783

    A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

    Not yet reported AbbVie 20 participants Est. completion 2022-10-14 6 sites Stand-alone
    Other conditions: Ulcerative Colitis (UC), Crohn's Disease
    View official trial listing →
  • Terminated NCT NCT04269850

    Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD

    Not yet reported, Not yet reported St. Petersburg State Pavlov Medical University 2 participants Est. completion 2024-11-27 1 site Stand-alone
    Other conditions: Intestinal GVHD
    View official trial listing →
  • Completed NCT NCT04282954

    Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease

    Not yet reported Onconic Therapeutics Inc. 188 participants Est. completion 2020-12-11 1 site
    Other conditions: GERD
    View official trial listing →
  • Withdrawn NCT NCT04294823

    Sensitivity and Specificity of the Modified Helicobacter Test INFAI

    International Pharmaceutical Consultancy Est. completion 2021-02 1 site
    Other conditions: Dyspepsia, GERD
    View official trial listing →
  • Completed NCT NCT04329000

    On-demand PPI Therapy is Effective on Controlling Symptoms in Patients With Barrett's Esophagus.

    Not yet reported Kaohsiung Veterans General Hospital. 218 participants Est. completion 2019-12-08
    Other conditions: Barrett Esophagus, Proton Pump Inhibitor, Symptom, Reflux
    View official trial listing →
  • Completed NCT NCT04348786

    Comparing Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinadizole on Treatment Helicobacter Pylori

    Not yet reported Damascus Hospital 78 participants Est. completion 2020-09-01 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT04359966

    Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia

    Not yet reported Slovenian Society for Gastroenterology and Hepatology 560 participants Est. completion 2023-09-30 3 sites
    Other conditions: Helicobacter Pylori Infection, Eradication Treatments
    View official trial listing →
  • Completed NCT NCT04368585

    Study to Examine the Effect of Antacid and Omeprazole on the Single-Dose Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Healthy Adult Subjects

    Not yet reported Spero Therapeutics 20 participants Est. completion 2020-08-21 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT04432233

    Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease

    Not yet reported Shanghai Jiao Tong University School of Medicine 60 participants Est. completion 2021-06-15 1 site
    Other conditions: Helicobacter Pylori Infection, Intravenous Drug Usage
    View official trial listing →
  • Completed NCT NCT04445948

    Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy

    Not yet reported Alexandria University 400 participants Est. completion 2020-06-21 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT04525664

    Assessment and Management of Chronic Dyspepsia in Eastern Uganda

    Not yet reported Washington University School of Medicine 376 participants Est. completion 2020-06-30 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection, Dyspepsia
    View official trial listing →
  • Enrolling by invitation NCT NCT04527055

    The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication

    Not yet reported National Cheng-Kung University Hospital 312 participants Est. completion 2028-07-31 1 site
    Other conditions: Helicobacter Pylori Infection, Dysbiosis, Probiotics
    View official trial listing →
  • Completed NCT NCT04531059

    Rescue Therapy for Helicobacter Pylori Eradication Treatment

    Not yet reported Shanghai Jiao Tong University School of Medicine 368 participants Est. completion 2022-12-31 3 sites
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT04558502

    Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 339 participants Est. completion 2022-12-05
    Other conditions: Helicobacter Pylori Eradication
    View official trial listing →
  • Completed NCT NCT04568772

    Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers

    Not yet reported Seoul National University Hospital 19 participants Est. completion 2021-08-03 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Status unknown NCT NCT04626193

    LOAD VS Levofloxacine Concomitant

    Not yet reported Damascus Hospital 80 participants Est. completion 2024-05-30 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT04652284

    Effectiveness of Rifabutin for Treatment of Helicobacter Pylori

    Not yet reported Rabin Medical Center 300 participants Est. completion 2023-07-31
    Other conditions: Helicobacter Infections, Resistance Bacterial, Gastritis H Pylori
    View official trial listing →
  • Completed NCT NCT04672018

    Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis

    Not yet reported University of Karachi 240 participants Est. completion 2023-02-02 1 site Stand-alone
    Other conditions: Gastritis
    View official trial listing →
  • Completed NCT NCT04676035

    The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 18 participants Est. completion 2022-01-26 1 site Stand-alone
    Other conditions: Prostate Cancer Patients
    View official trial listing →
  • Completed NCT NCT04678492

    Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

    Not yet reported Xijing Hospital of Digestive Diseases 658 participants Est. completion 2021-12-20 1 site
    Other conditions: Gastritis, Dyspepsia, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT04679948

    A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood

    Not yet reported Boehringer Ingelheim 16 participants Est. completion 2021-03-17 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT04721704

    Comparison of Efficacy of Triple Regimen Based on Clarithromycin VS Metronidazole in Children

    Not yet reported Shaheed Zulfiqar Ali Bhutto Medical University 36 participants Est. completion 2022-09-14 2 sites Stand-alone
    Other conditions: H Pylori Gastritis
    View official trial listing →
  • Completed NCT NCT04753437

    A Study of Vonoprazan in Adults With Helicobacter Pylori

    Not yet reported Takeda 44 participants Est. completion 2021-11-05 1 site
    Other conditions: Helicobacter Pylori
    View official trial listing →
  • Terminated NCT NCT04766996

    PROUD Study - Preventing Opioid Use Disorders

    Not yet reported Emory University 57 participants Est. completion 2021-12-27 1 site
    Other conditions: Anesthesia, Opioid Use
    View official trial listing →
  • Status unknown NCT NCT04803162

    The Role of HRM and Specific Biomarkers of Inflammation in the Diagnosis of Patients With Dysphagia and Suspected EoE

    Wroclaw Medical University 58 participants Est. completion 2021-12 1 site
    Other conditions: Eosinophilic Esophagitis
    View official trial listing →
  • Completed NCT NCT04834752

    Effect of H2 Receptor Antagonist and Proton Pump Inhibitor on the Positivity Rates and Clinical Outcomes of COVID-19

    Seoul National University Hospital 400000 participants Est. completion 2021-12-31 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04840641

    Flucloxacillin as an Inducer of CYP-enzymes

    Not yet reported University of Southern Denmark 14 participants Est. completion 2021-12-28 1 site
    Other conditions: Healthy Volunteers, Drug Drug Interaction
    View official trial listing →
  • Completed NCT NCT04840888

    A Study of LY3484356 in Healthy Female Participants

    Not yet reported Eli Lilly and Company 82 participants Est. completion 2022-04-12 2 sites Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04865731

    Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer

    Not yet reported The University of Texas Health Science Center at San Antonio 6 participants Est. completion 2024-06-18 1 site
    Other conditions: Cancer of the Head and Neck
    View official trial listing →
  • Completed NCT NCT04876807

    A Study to Evaluate the Effect of an Acidic Formulation of Acalabrutinib (ACP-196), Acidic Beverage, or Grapefruit Juice on the Pharmacokinetics (PK) of ACP-196 Alone and Coadministered With Omeprazole

    Not yet reported Acerta Pharma BV 36 participants Est. completion 2016-03-15 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04914936

    A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196

    Not yet reported Acerta Pharma BV 72 participants Est. completion 2014-10-16 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Terminated NCT NCT04959266

    A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib

    Not yet reported AstraZeneca 5 participants Est. completion 2022-06-01 5 sites Stand-alone
    Other conditions: Advanced Solid Tumours
    View official trial listing →
  • Terminated NCT NCT04990804

    Opioid Free vs. Standard Perioperative Pain Regimen for Anterior Cervical Discectomy and Fusion (ACDF) Surgery

    Not yet reported Vanderbilt University Medical Center 8 participants Est. completion 2022-02-01 1 site Stand-alone
    Other conditions: Opioid Use, Spinal Diseases, Surgery--Complications, Surgery, Postoperative Pain
    View official trial listing →
  • Completed NCT NCT05051566

    A Multiple Dose Study of LY3502970 in Healthy Participants

    Not yet reported Eli Lilly and Company 26 participants Est. completion 2022-04-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05061563

    A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults

    Not yet reported Bayer 14 participants Est. completion 2022-02-23 1 site
    Other conditions: Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men, Hot Flashes
    View official trial listing →
  • Completed NCT NCT05067439

    A Study to Estimate the Effect of Multiple Dose Abrocitinib on Caffeine, Efavirenz, and Omeprazole in Healthy Participants

    Not yet reported Pfizer 26 participants Est. completion 2022-02-26 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Status unknown NCT NCT05100446

    Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection

    Not yet reported Unidade Local de Saúde do Alto Ave, EPE 100 participants Est. completion 2022-12-31 1 site
    Other conditions: Helicobacter Pylori Infection, Gastritis, Gastric Cancer
    View official trial listing →
  • Completed NCT NCT05109390

    A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults

    Not yet reported Alexion Pharmaceuticals, Inc. 72 participants Est. completion 2018-10-17 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05237115

    Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy

    Not yet reported Xijing Hospital of Digestive Diseases 600 participants Est. completion 2020-12-05 1 site
    Other conditions: Gastritis, Peptic Ulcer, Dyspepsia
    View official trial listing →
  • Completed NCT NCT05254548

    A Study to Investigate the Effect of Single and Repeated Oral Doses of ACT-539313 on What the Body Does to Flurbiprofen, Omeprazole, Midazolam in Healthy Subjects

    Not yet reported Idorsia Pharmaceuticals Ltd. 22 participants Est. completion 2022-04-13 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05256342

    Biomarkers for Prediction of Analgesic Efficacy in Knee OA.

    Not yet reported Rambam Health Care Campus 17 participants Est. completion 2024-04-08 2 sites
    Osteoarthritis Other conditions: Biomarkers for Prediction of OA Treatment Efficacy
    View official trial listing →
  • Completed NCT NCT05265247

    Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants

    Not yet reported HALEON 61 participants Est. completion 2022-06-02 1 site
    Other conditions: Gastrointestinal Diseases
    View official trial listing →
  • Completed NCT NCT05287633

    Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting

    Not yet reported, Not yet reported University of Monastir 500 participants Est. completion 2024-12-30 1 site
    Other conditions: Dyspepsia
    View official trial listing →
  • Completed NCT NCT05319899

    A Study of ALXN1840 (Non-coated) Administered With And Without Omeprazole In Healthy Adults

    Not yet reported Alexion Pharmaceuticals, Inc. 18 participants Est. completion 2014-03-24 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05342532

    High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population

    Not yet reported Icahn School of Medicine at Mount Sinai 112 participants Est. completion 2022-01-01 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05467475

    A Study in Healthy Men to Test How Esomeprazole Influences the Amount of BI 1819479 in the Blood

    Not yet reported Boehringer Ingelheim 15 participants Est. completion 2023-01-23 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05468164

    A Study of Effect of Food and a Proton Pump Inhibitor on Selpercatinib (LY3527723) in Healthy Participants

    Not yet reported Eli Lilly and Company 20 participants Est. completion 2018-09-13 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT05474924

    The Role of Budesonide Intrapolyp Injection in CRSwNP

    Not yet reported Kafrelsheikh University 90 participants Est. completion 2022-12-01 1 site
    Other conditions: CRS, Polyp, Nasal
    View official trial listing →
  • Completed NCT NCT05497557

    A Study to Evaluate the Impact of Omeprazole on the Pharmacokinetics of Sotorasib Co-administered With an Acidic Beverage in Healthy Volunteers

    Not yet reported Amgen 16 participants Est. completion 2022-09-08 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05563350

    Metabolism of Chlordiazepoxide in the Treatment of Alcohol Withdrawal Symptoms

    University Hospital Bispebjerg and Frederiksberg 26 participants Est. completion 2023-07-01 1 site
    Other conditions: Alcohol Withdrawal
    View official trial listing →
  • Completed NCT NCT05577468

    Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori

    Not yet reported Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. 561 participants Est. completion 2023-09-30 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT05586464

    Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Traditional Chinese Medicine

    Not yet reported Liaocheng People's Hospital 600 participants Est. completion 2024-09-30
    Other conditions: Helicobacter Pylori Infection, Traditional Chinese Medicine, Eradication
    View official trial listing →
  • Completed NCT NCT05609929

    Study the Effect of Omeprazole on AB-106 Pharmacokinetics

    Not yet reported Nuvation Bio Inc. 24 participants Est. completion 2023-01-20 1 site Stand-alone
    Other conditions: Pharmacokinetic Study
    View official trial listing →
  • Not yet recruiting NCT NCT05624229

    Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding

    Not yet reported West China Hospital 672 participants Est. completion 2028-12-31
    Other conditions: Upper Gastrointestinal Hemorrhage
    View official trial listing →
  • Status unknown NCT NCT05651074

    Assessment of the Effect of Omeprazole on Vicagrel in Healthy Subjects

    Not yet reported Jiangsu vcare pharmaceutical technology co., LTD 20 participants Est. completion 2023-04 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT05657613

    Drug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects

    Not yet reported CTI BioPharma 60 participants Est. completion 2023-06-08 1 site Stand-alone
    Other conditions: Drug Interactions
    View official trial listing →
  • Terminated NCT NCT05671653

    A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range

    Not yet reported Pfizer 32 participants Est. completion 2023-11-03 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT05726734

    Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial

    Not yet reported Shanghai East Hospital 100 participants Est. completion 2026-02-06 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05741385

    A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

    Not yet reported Boehringer Ingelheim 4 participants Est. completion 2024-08-23 1 site Stand-alone
    Other conditions: Liver Cirrhosis
    View official trial listing →
  • Terminated NCT NCT05753774

    Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders

    Not yet reported Biao Zou 47 participants Est. completion 2026-03-09 1 site
    Other conditions: Functional Gastrointestinal Disorders
    View official trial listing →
  • Status unknown NCT NCT05802888

    Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.

    Not yet reported Shandong University 260 participants Est. completion 2024-06-15 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05826574

    A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants

    Not yet reported Insmed Incorporated 32 participants Est. completion 2023-07-16 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05841394

    A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding

    Not yet reported Livzon Pharmaceutical Group Inc. 449 participants Est. completion 2022-04-28 2 sites
    Other conditions: Stress Ulcer Bleeding
    View official trial listing →
  • Completed NCT NCT05861687

    Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children

    Not yet reported, Not yet reported Finni Kollins 51 participants Est. completion 2022-05-20 2 sites
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05863858

    Eradication of H. Pylori Infection With Moxifloxacin

    Not yet reported Iyad Naeem Muhammad, PhD 162 participants Est. completion 2022-06-08 1 site
    Other conditions: Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to
    View official trial listing →
  • Status unknown NCT NCT05870683

    Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection （SHARE2301）

    Not yet reported Yanqing Li 368 participants Est. completion 2023-12-30 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT05925140

    LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients

    Not yet reported Lebanese University 1000 participants Est. completion 2025-12-30 2 sites Stand-alone
    Other conditions: COVID-19, Hospitalized COVID-19 Patients
    View official trial listing →
  • Completed NCT NCT05932277

    A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants

    Not yet reported Bristol-Myers Squibb 22 participants Est. completion 2023-09-13 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05981365

    Voxelotor CYP and Transporter Cocktail Interaction Study

    Not yet reported Pfizer 44 participants Est. completion 2023-10-04 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT06031454

    Drug-durg Interaction of Leritrelvir(RAY1216) With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin

    Not yet reported Guangdong Raynovent Biotech Co., Ltd 56 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Drug Drug Interaction
    View official trial listing →
  • Completed NCT NCT06050824

    A Comparative Study Between Concomitant Versus Load Therapy in Eradication of Helicobacter Pylori Infection

    Not yet reported Helwan University 200 participants Est. completion 2023-07-19 1 site
    Other conditions: H. Pylori Infection
    View official trial listing →
  • Completed NCT NCT06093945

    Effect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 20 participants Est. completion 2023-11-29 1 site Stand-alone
    Other conditions: Malignant Tumor
    View official trial listing →
  • Completed NCT NCT06101420

    Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication

    Not yet reported Ain Shams University 232 participants Est. completion 2023-06-01 1 site
    Other conditions: Helicobacter Pylori Eradication
    View official trial listing →
  • Completed NCT NCT06162169

    A Clinical Trial to Evaluate JAB-21822 Drug-drug Interactions in Healthy Subjects

    Not yet reported Allist Pharmaceuticals, Inc. 66 participants Est. completion 2024-02-20 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT06162949

    Vonoprazan for Helicobacter Pylori Eradication in Adolescents

    Not yet reported Alexandria University 242 participants Est. completion 2024-08-01 1 site
    Other conditions: Treatment Effectiveness
    View official trial listing →
  • Completed NCT NCT06168084

    Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

    Not yet reported Yongquan Shi 688 participants Est. completion 2024-08-30 2 sites
    Other conditions: Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT06193811

    A Study in Healthy People to Compare Two Different Tablets of BI 685509 and to Test How Food and Esomeprazole Influence the Amount of BI 685509 in the Blood

    Not yet reported Boehringer Ingelheim 16 participants Est. completion 2024-03-14 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06213818

    A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant

    Not yet reported Incyte Corporation 137 participants Est. completion 2025-08-19 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT06215430

    A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9, CYP2C19 Substrates in Healthy Participants

    Not yet reported Eli Lilly and Company 16 participants Est. completion 2021-04-15 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT06216639

    Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection

    National Institute of Public Health, Slovenia 2000 participants Est. completion 2025-01 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT06233097

    Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition

    Not yet reported Bio-innova Co., Ltd 30 participants Est. completion 2024-10-12
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT06233149

    Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fed Condition

    Not yet reported Bio-innova Co., Ltd 40 participants Est. completion 2024-12-03
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT06250634

    Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection

    Not yet reported The Third Xiangya Hospital of Central South University 806 participants Est. completion 2024-05-10 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT06268834

    Is Long-Term Proton Pump Inhibitor Use a Cause of Leaky Gut Syndrome

    Not yet reported Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital 75 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Proton Pump Inhibitor Adverse Reaction
    View official trial listing →
  • Completed NCT NCT06275841

    A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Vepdegestrant

    Not yet reported Pfizer 12 participants Est. completion 2024-05-24 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT06302049

    Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis

    Not yet reported, Not yet reported Sadat City University 46 participants Est. completion 2026-05-01 1 site
    Other conditions: Fatty Liver Disease, Steatohepatitis, Nonalcoholic
    View official trial listing →
  • Completed NCT NCT06315478

    Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians

    Not yet reported Helwan University 60 participants Est. completion 2021-11-01 1 site
    Other conditions: H.Pylori Infection
    View official trial listing →
  • Completed NCT NCT06378658

    A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants

    Not yet reported Bayer 21 participants Est. completion 2024-06-11 1 site
    Other conditions: Advanced Non-small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06419660

    A Study in Healthy Men to Test Whether Esomeprazole Influences the Amount of BI 3000202 in the Blood

    Not yet reported Boehringer Ingelheim 15 participants Est. completion 2024-07-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Enrolling by invitation NCT NCT06509139

    Optimal Duration of Bismuth Quadruple Therapy for Helicobacter Pylori Eradication in Females As Compared with Males

    Not yet reported National Cheng-Kung University Hospital 661 participants Est. completion 2032-07-31 1 site
    Other conditions: Helicobacter Pylori Infection, Sex, Bismuth Quadruple Therapy
    View official trial listing →
  • Completed NCT NCT06514274

    Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication

    Not yet reported Xijing Hospital of Digestive Diseases 558 participants Est. completion 2025-06-25 1 site
    Other conditions: Helicobacter Pylori Infection, Chronic Gastritis
    View official trial listing →
  • Not yet recruiting NCT NCT06526455

    Efficacy and Safety of Vonorasan Versus Esomeprazole in the Treatment of Ulcers After Endoscopic Submucosal Dissection

    Not yet reported Shicai Ye 196 participants Est. completion 2029-06-30 4 sites
    Other conditions: Ulcers, Gastric
    View official trial listing →
  • Status unknown NCT NCT06539494

    Luminal Fructose Kinetics (MARTINI Study)

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 22 participants Est. completion 2026-04 1 site
    MASLD
    View official trial listing →
  • Status unknown NCT NCT06561542

    A Phase I Study of LX22001 for Injection in Healthy Subjects

    Not yet reported Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. 70 participants Est. completion 2025-11-21 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06566794

    KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism

    Not yet reported Helsinki University Central Hospital 12 participants Est. completion 2025-01-10 1 site
    Other conditions: Drug Interaction
    View official trial listing →
  • Not yet recruiting NCT NCT06720610

    Indonesian Study of Vonoprazan Vs Esomeprazole in Erosive Esophagitis

    Not yet reported Indonesia University 216 participants Est. completion 2025-06-27 5 sites
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Completed NCT NCT06793943

    A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults

    Not yet reported Takeda 78 participants Est. completion 2025-03-30 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Not yet recruiting NCT NCT06810492

    The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment

    Not yet reported Hongmei Zheng, PhD 40 participants Est. completion 2027-12-01
    Other conditions: Breast Cancer Stage III, Breast Cancer Stage II
    View official trial listing →
  • Status unknown NCT NCT06811207

    Comparison of the Efficacies of Two Novel Dose Dual Therapies in the First-line Helicobacter Pylori Eradication

    Not yet reported Chang Gung Memorial Hospital 300 participants Est. completion 2025-02-28 1 site
    Other conditions: HELICOBACTER PYLORI INFECTIONS
    View official trial listing →
  • Completed NCT NCT06822166

    Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride

    Not yet reported Ahon Pharmaceutical Co., Ltd. 68 participants Est. completion 2024-01-23 1 site Stand-alone
    Other conditions: Interaction Drug Food
    View official trial listing →
  • Completed NCT NCT06823791

    Furazolidone Quadruple Regimen Eradicate H. Pylori Infection

    Not yet reported, Not yet reported Liaocheng People's Hospital 493 participants Est. completion 2024-07-30 1 site
    Other conditions: Helicobacter Pylori Infection, Eradication
    View official trial listing →
  • Not yet recruiting NCT NCT06943794

    Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial

    Not yet reported Fudan University 4824 participants Est. completion 2030-12-30 1 site Stand-alone
    Other conditions: Gastric (Stomach) Cancer
    View official trial listing →
  • Completed NCT NCT06949124

    A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 20 participants Est. completion 2025-06-05 1 site
    Other conditions: Endometriosis, Uterine Fibroids, Assisted Reproduction
    View official trial listing →
  • Completed NCT NCT06973889

    Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients

    Not yet reported Mashhad University of Medical Sciences 60 participants Est. completion 2025-01-21 2 sites Stand-alone
    Other conditions: HELICOBACTER PYLORI INFECTIONS, Gastrointestinal Disease
    View official trial listing →
  • Completed NCT NCT06975605

    Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.

    Not yet reported GRIN Therapeutics, Inc. 18 participants Est. completion 2025-07-10 1 site Stand-alone
    Other conditions: Tuberous Sclerosis Complex (TSC), Focal Cortical Dysplasia, Other Neurological Disorders
    View official trial listing →
  • Not yet recruiting NCT NCT07040839

    Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection

    Not yet reported Rehman Medical Institute - RMI 128 participants Est. completion 2026-02 1 site Stand-alone
    Other conditions: H Pylori
    View official trial listing →
  • Completed NCT NCT07086937

    Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children

    Not yet reported Muhammad Aamir Latif 66 participants Est. completion 2025-06-30 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT07142486

    Effects of Omeprazole Ingestion on Postprandial Amino Acid Concentrations in Response to a Mixed Meal

    Not yet reported McGill University 4 participants Est. completion 2026-06-19 1 site
    Other conditions: Digestive Health, Gastrointestinal Health
    View official trial listing →
  • Terminated NCT NCT07214662

    A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer

    Not yet reported Genentech, Inc. 3 participants Est. completion 2026-06-24 4 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07312370

    Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing

    Not yet reported LanZhou University 120 participants Est. completion 2026-12-30 1 site
    Other conditions: Early Gastric Cancer, Gastric Dysplasia, Gastric Neoplasms, Peptic Ulcer With Haemorrhage, Gastric Ulcer
    View official trial listing →
  • Completed NCT NCT07312721

    Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis

    Not yet reported Azfar Farogh 752 participants Est. completion 2024-12-30 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection, Chronic Gastritis, Peptic Ulcer Disease
    View official trial listing →
  • Completed NCT NCT07326904

    Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease

    Not yet reported Indonesia University 145 participants Est. completion 2024-12-13 3 sites
    Other conditions: Gastro Oesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT07487142

    Prevalence of Asymptomatic H Pylori Infection Among Patients Undergoing PCI and Impact of Its Eradication on Occurrence of GIT Symptoms and Bleeding"

    Not yet reported Beni-Suef University 121 participants Est. completion 2025-12-24 1 site
    Other conditions: H Pylori Infection
    View official trial listing →
  • Completed NCT NCT07563491

    Comparison of Esomeprazole Versus Vonoprazan in Gastroesophageal Reflux Disease

    Not yet reported Muhammad Aamir Latif 824 participants Est. completion 2025-09-30 1 site
    Other conditions: Gastro Esophageal Reflux
    View official trial listing →
  • Not yet recruiting NCT NCT07654049

    Study of Teprenone in the Treatment of Glucocorticoid-Induced Drug-Related Gastrointestinal Injury

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 100 participants Est. completion 2027-06-01
    Other conditions: Gastrointestinal and Digestive Disorder
    View official trial listing →
  • Not yet recruiting NCT NCT07729293

    Pylori Duo for Adjunctive Treatment and Prevention of Recurrence of Helicobacter Pylori Infection

    Not yet reported Gala Servicios Clinicos S.L. 140 participants Est. completion 2028-09-30 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection, Dyspepsia, Gastrointestinal Adverse Effects
    View official trial listing →
  • Not yet recruiting NCT NCT07746934

    Metronidazole- Versus Tinidazole-Based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

    Not yet reported University of Medicine and Pharmacy at Ho Chi Minh City 600 participants Est. completion 2027-12-27 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Not yet recruiting NCT NCT07772700

    Potassium-competitive Acid Blocker Versus Double Dose Proton Pump Inhibitors in High High-risk Peptic Ulcer Bleeding

    Not yet reported National Cheng-Kung University Hospital 108 participants Est. completion 2027-12-31
    Other conditions: Bleeding
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.